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Introduction
Close coordination between chromosome segregation and cytoki­
nesis is crucial for proper cell division and inheritance of the ge­
netic material. For example, division plane positioning defects 
can lead to chromosome segregation anomalies and aneuploidy 
and can also perturb cell organization or cell lineage during early 
development of multicellular organisms.
In animal cells, division plane positioning is regulated by 
positive and negative spatial cues emanating from the spindle 
midzone and spindle poles, respectively, ensuring a direct spa­
tial coordination between chromosome segregation and cyto­
kinesis (Balasubramanian et al., 2012; Fededa and Gerlich, 
2012; Green et al., 2012; White and Glotzer, 2012). Similarly, 
in the fission yeast Schizosaccharomyces pombe, a combination 
of positive and negative spatial cues act to establish the position 
of the division plane in the middle of this rod­shaped single­celled 
organism (Oliferenko et al., 2009; Almonacid and Paoletti, 
2010; Rincon and Paoletti, 2012).
Positive signaling of the division plane involves the nuclear 
export of the anillin­like protein Mid1 (Sohrmann et al., 1996), 
which spatially couples the position of the nucleus during in­
terphase to the assembly site of the cytokinetic ring (Daga and 
Chang, 2005; Almonacid et al., 2009). This mechanism leads to 
Mid1 accumulation on juxtanuclear regions of the cortex, where 
Mid1 forms cytokinetic ring precursor nodes and, upon activa­
tion by the polo­like kinase Plo1, promotes the sequential re­
cruitment of essential components of the contractile ring (Bathe 
and Chang, 2010; Laporte et al., 2010; Pollard and Wu, 2010; 
Almonacid et al., 2011; Goyal et al., 2011; Lee et al., 2012).
This mitotic recruitment phase starts with the recruitment 
of myosin II in an IQGAP (IQ domain GTPase­activating pro­
tein)/Rng2­dependent manner followed by the F­BAR (FER/CIP4 
homology domain­Bin­Amphiphysin­Rvs–like protein) protein 
Proper division plane positioning is essential to achieve faithful DNA segregation and to control daughter cell size, positioning, or fate within tissues. 
In Schizosaccharomyces pombe, division plane position-
ing is controlled positively by export of the division plane 
positioning factor Mid1/anillin from the nucleus and neg-
atively by the Pom1/DYRK (dual-specificity tyrosine- 
regulated kinase) gradients emanating from cell tips. 
Pom1 restricts to the cell middle cortical cytokinetic ring 
precursor nodes organized by the SAD-like kinase Cdr2 
and Mid1/anillin through an unknown mechanism. In this 
study, we show that Pom1 modulates Cdr2 association 
with membranes by phosphorylation of a basic region co-
operating with the lipid-binding KA-1 domain. Pom1 also 
inhibits Cdr2 interaction with Mid1, reducing its clustering 
ability, possibly by down-regulation of Cdr2 kinase activ-
ity. We propose that the dual regulation exerted by Pom1 
on Cdr2 prevents Cdr2 assembly into stable nodes in the 
cell tip region where Pom1 concentration is high, which 
ensures proper positioning of cytokinetic ring precursors 
at the cell geometrical center and robust and accurate di-
vision plane positioning.
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Cdk1 activity (Martin and Berthelot­Grosjean, 2009; Mose­
ley et al., 2009). Cdr2 cortical nodes indeed contain several 
regulators of mitotic entry, including Cdr2 itself, which acts as 
a Wee1­inhibitory kinase (Breeding et al., 1998; Kanoh and 
Russell, 1998), the Cdr1/Nim1 kinase homologous to Cdr2 
(Russell and Nurse, 1987a; Coleman et al., 1993; Parker et al., 
1993; Wu and Russell, 1993), and the Cdk1 inhibitor Wee1 
(Russell and Nurse, 1987b; Moseley et al., 2009). Collectively, 
these constitute a Wee1­inhibitory network. In the proposed 
models, Pom1 maintains this Wee1­inhibitory network inactive 
in short cells, preventing mitotic entry until a critical length has 
been reached (Martin and Berthelot­Grosjean, 2009; Moseley 
et al., 2009). Whether the Pom1–Cdr2 pathway constitutes an 
active cell size sensor has nevertheless been recently challenged 
(Wood and Nurse, 2013). Recent data indicate that this role of 
Pom1 in regulating division timing is genetically separable from 
its role in division plane positioning (Bhatia et al., 2014) and 
involves Pom1 indirectly regulating the kinase activity of Cdr2 
by phosphorylation of the C­terminal tail, which antagonizes 
the phosphorylation of Cdr2 T loop by the calcium/calmodulin­
dependent protein kinase kinase Ssp1 (Bhatia et al., 2014; Deng 
et al., 2014).
In contrast, the molecular mechanisms underlying how 
Pom1 gradients negatively regulate Cdr2 node distribution are 
not understood. Here, we have deciphered the mechanisms by 
which Cdr2 assembles into nodes on the cell cortex and dissected 
how the spatial information of Pom1 gradients is transduced 
into functional outputs for division plane positioning. Similar to 
Pom1 gradients, several dynamic gradients are known to pro­
vide spatial subcellular information to establish stable domains 
with specific biochemical activities (Fuller, 2010). Yet, in most 
cases, how the spatial information is transduced to target activities 
remains unclear. Our study provides a first mechanistic model 
that might be relevant to other spatial regulatory events involv­
ing membrane gradients.
Results
The Cdr2 KA-1 domain and a neighboring 
basic region cooperate to promote Cdr2 
membrane binding
To understand how Pom1 constrains Cdr2 node distribution at 
the cell medial cortex to predefine the division plane, we first 
studied how Cdr2 associates with the cortex. A large region of 
Cdr2 of 500 amino acids C terminal to the kinase domain 
was previously shown to be necessary and sufficient for Cdr2 
cortical localization (Morrell et al., 2004). This region includes 
a predicted structured domain of 130 amino acids composed 
of three putative  helices and five  sheets (Fig. 1 A) with low 
similarity to the recently described lipid­binding KA­1 domain 
of Kcc4, a kinase homologous to Cdr2 in Saccharomyces cere-
visiae (Moravcevic et al., 2010). Mutations in any of the three 
 helices completely detached Cdr2 from the cortex (Fig. S1 A) 
and induced Cdr2 relocalization to the nucleus, indicating that 
the lipid­binding function of this domain may be conserved.
Surprisingly, homology modeling of the Cdr2 KA­1 do­
main, based on the crystal structure of Kcc4 KA­1 (Fig. 1 B), 
Cdc15 and F­actin nucleator Cdc12 (Almonacid et al., 2011; 
Laporte et al., 2011; Padmanabhan et al., 2011). Compaction of 
mature ring precursors driven by actomyosin forces then leads 
to the formation of a medially placed contractile ring (Vavylonis 
et al., 2008; Ojkic et al., 2011).
In mid1 cells, actomyosin strands or contractile rings as­
semble at random positions within the cell. Contractile ring as­
sembly then depends on the septation initiation network (Hachet 
and Simanis, 2008; Huang et al., 2008), which regulates Cdc15 
conformation through Clp1­dependent dephosphorylation and 
inhibits Cdc12 multimerization by Sid2­dependent phosphory­
lation (Roberts­Galbraith et al., 2010; Bohnert et al., 2013). 
Nevertheless, mid1 mutation or deletion yields extensive cell 
death in the cell population (Chang et al., 1996; Sohrmann et al., 
1996), indicating that Mid1­dependent regulation of the con­
tractile ring position contributes to cell survival and proper seg­
regation of chromosomes between sister cells.
A parallel pathway regulating division plane positioning in 
fission yeast relies on a negative cue that emanates from cell tips 
in the form of spatial gradients of the dual­specificity tyrosine­
regulated kinase (DYRK) family kinase Pom1 (Bähler and Pringle, 
1998; Celton­Morizur et al., 2006; Padte et al., 2006). Pom1 
membrane diffusion­based gradients are nucleated by microtu­
bule­dependent delivery of the Tea protein complexes to the cell 
tips where they anchor a PP1 phosphatase (Alvarez­Tabarés 
et al., 2007; Martin, 2009; Hachet et al., 2012). PP1 reverses Pom1 
autophosphorylation on its membrane­anchoring domain, which 
otherwise promotes a progressive detachment of Pom1 from the 
plasma membrane as Pom1 diffuses away from the cell tip region 
(Hachet et al., 2011; Saunders et al., 2012). Pom1, in turn, has 
been shown to control the distribution of Cdr2 (Breeding et al., 
1998; Kanoh and Russell, 1998), a conserved member of the 
Brsk/SAD (synapses of the amphid defective)/Septin kinase sub­
family of AMP kinase–like kinases that assembles into nodes on 
the cortex (Morrell et al., 2004). In pom1 cells, growth is mono­
polar, and Cdr2 nodes, normally restricted to the medial cortex, 
invade the nongrowing cell tip (Martin and Berthelot­Grosjean, 
2009; Moseley et al., 2009). Surprisingly, Cdr2 nodes remain ex­
cluded from the growing tip, but the mechanism of this additional 
Pom1­independent regulation remains unknown.
Importantly, Cdr2 nodes recruit Mid1 to the medial cortex 
during interphase and gradually collect a series of nonessential 
ring components (e.g., Blt1, Gef2, and Nod1) released from the 
previous division site (Almonacid et al., 2009; Moseley et al., 
2009; Ye et al., 2012; Guzman­Vendrell et al., 2013; Jourdain 
et al., 2013; Zhu et al., 2013; Akamatsu et al., 2014). As a result, 
in pom1 cells, the distribution of contractile ring precursors 
is perturbed, leading to asymmetric division (Celton­Morizur 
et al., 2006; Padte et al., 2006). Thus, Pom1­dependent regula­
tion of Cdr2 node distribution on the cortex allows preposition­
ing of Mid1 to the geometric center of the cell. This pathway, 
which is necessary to promote the formation of equally sized 
sister cells when Mid1 shuttling in the nucleus is impaired, con­
tributes to the robustness and accuracy of division plane posi­
tioning in wild­type cells.
Interestingly, Pom1 and Cdr2 regulate not only division 
plane positioning but also division timing by modulation of 
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Figure 1. C-terminal KA-1 domain and basic motif mediate Cdr2 membrane binding. (A) Schematic representation of full-length Cdr2 (top) and Cdr2 C- 
terminal cortex-anchoring domain (Cdr2-Cter, residues 591–747; bottom) composed of a basic region (blue) and a KA-1 domain (green on top and rainbow 
on the bottom). Predicted  helices and  sheets of the KA-1 domain are shown. (B) Structural model of Cdr2 KA-1 domain derived from the S. cerevisiae 
Kcc4 KA-1 crystal structure (Protein Data Bank accession no. 3OST). Seven positively charged residues sticking out of the domain are highlighted in blue. 
(C) Epifluorescence medial plane images of mEGFP-tagged Cdr2 mutants of the positively charged residues of Cdr2 KA-1 shown in B (Cdr2RR*: R624Q 
and R628Q; Cdr2RKRKR*: R682Q, K684N, R685Q, K692N, and R695Q; Cdr2RR*-RKRKR*: combination of all mutations), in the basic region upstream of 
Cdr2 KA-1 (Cdr2bsc*: K598N, H599Q, R600Q, R601Q, R602Q, K612N, K613N, and K614N), or in both (Cdr2bsc*-RKRKR*). Bar, 5 µm. (D) Mean FRAP of 
mEGFP-tagged Cdr2 or Cdr2RR* and Cdr2bsc mutants on the medial cortex as indicated. Error bars show SDs. Cdr2 t1/2 = 3 min; Cdr2RR* t1/2 = 3 min; 
Cdr2bsc t1/2 < 1 min. B, bleach.
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revealed that surface­exposed basic residues mediating the 
electrostatic interactions with acidic phospholipids in Kcc4 
KA­1 (Moravcevic et al., 2010) were not conserved in Cdr2 
KA­1 (Fig. S1 B). In addition, some hydrophobic residues of 
the 3–4 hydrophobic loop proposed to insert into the lipid 
bilayer were replaced by nonhydrophobic residues. Instead, 
we identified a cluster of surface­exposed basic residues in 
3, 4, and the 3–4 loop (R682, K684, R685, K692, and 
R695). Mutagenesis of these basic residues to noncharged 
polar amino acids (N or Q) showed that these residues have 
an important role in targeting Cdr2 to the cortex (Fig. 1 C). 
Mutations of two other basic residues from helix 1 (R624 
and R628) did not affect Cdr2 association with the cortex on 
their own but led to a complete detachment when combined 
with mutations of the aforementioned five basic residues. 
Thus, a series of surface­exposed basic residues in Cdr2 KA­
1 may cooperatively establish electrostatic interactions with 
negatively charged phospholipids.
The Cdr2 KA­1 domain is preceded by a basic motif 
(8 out of 17 positively charged residues; Fig. 1 A), whose dele­
tion, or mutation of basic residues, resulted in a partial delo­
calization of Cdr2 from the cortex and appearance of a nuclear 
pool (Figs. 1 C and S1 A). In combination with mutation of the 
five basic residues close to the 3–4 loop, this led to complete 
detachment of Cdr2 from the cortex. Thus, the basic motif coop­
erates with Cdr2 KA­1 to promote Cdr2 anchoring at the cortex. 
FRAP experiments further revealed that the localization defects 
observed in the various cortex­anchoring mutants described in 
this paper correlated with increased dynamic exchange of Cdr2 
on the cortex (Fig. 1 D). These mutants also produced longer 
cells, with stronger Cdr2 localization defects correlating with 
longer delays in mitotic entry (Table S3), indicating that Cdr2 
cortical localization is crucial for its function.
Cdr2 clustering involves both the KA-1 
domain and Cdr2 N-terminal interaction 
with Mid1
A C­terminal region composed of the Cdr2 basic motif and 
KA­1 domain (residues 591–747), hereafter called Cdr2­Cter, 
was sufficient for cortex binding (Fig. 2 A). Similar to the Kcc4 
KA­1 domain (Moravcevic et al., 2010), recombinant Cdr2­ 
Cter also bound in vitro on lipid strips to phosphatidylserine, a 
major acidic phospholipid of the plasma membrane (Fig. S1 C). 
We also observed minor binding to phosphatidic acid and car­
diolipin but not to phosphoinositides. Thus, Cdr2­Cter is neces­
sary and sufficient for localization to the plasma membrane.
Interestingly, Cdr2­Cter formed small clusters on the me­
dial cortex in contrast to the equivalent C­terminal domain of 
Figure 2. Clustering properties of the Cdr2-Cter domain. (A, top) Medial 
plane epifluorescence images of GFP–Cdr2-Cter (residues 591–747) and 
GFP–Kcc4-Cter (residues 893–1,037). Bar, 5 µm. (bottom) 1.75× mag-
nification of boxed regions. Bar, 1 µm. (B) Fluorescence intensity along 
the cortex in regions boxed in A, representative of the cell population. 
(C) Pull-down assay between differentially tagged Cdr2-Cter or Kcc4-Cter. 
Overexpressed GST–Cdr2-Cter or GST–Kcc4-Cter was coupled to gluta-
thione beads and mixed with extracts of cells expressing Cdr2-Cter–myc12 
or Kcc4-Cter–myc12, respectively. Cdr2-Cter and Kcc4-Cter were revealed 
in input and pull-down fractions with anti-GST or antimyc antibodies. 
(right) Normalized Cter-myc signals in GST pull-down measured in two 
independent experiments. Molecular masses are indicated. (D) Cdr2 KA-
1 model highlighting the two hydrophobic residues of the 4–5 loop 
(F704 and F705) and the Kcc4 KA-1 structure 3OST (Moravcevic et al., 
2010), in which the equivalent loop contains a charged residue (D1001) 
surrounded by two neutral residues (G1000 and G1002; not depicted). 
A.U., arbitrary unit; WB, Western blot.
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Comparing our Cdr2 KA­1 structural model to the Kcc4 
crystallographic structure, we found that the 4–5 loop of the 
Cdr2 KA­1, opposite to the membrane­binding surface, is very 
hydrophobic, whereas the same loop is negatively charged in 
Kcc4 (Fig. 2 D). Remarkably, mutations of the hydrophobic 
residues F704 and F705 to aspartic acid (D) abolished Cdr2­
Cter clustering (Fig. 3, A and B). Moreover, the interaction 
between differentially tagged Cdr2­CterFF* mutants was strongly 
impaired in pull­down experiments (Fig. 3 C). Intriguingly, 
Kcc4, which was distributed homogeneously on the cortex 
when expressed in fission yeast (Fig. 2, A and B). This sug­
gested to us that Cdr2 KA­1 may have unique oligomerization 
properties, not shared with Kcc4 KA­1, which may contribute 
to Cdr2 assembly into nodes and also allow multivalent mem­
brane binding with high avidity (Lemmon, 2008). Accordingly, 
we found that differentially tagged wild­type Cdr2­Cter mole­
cules interacted in pull­down experiments, whereas correspond­
ing Kcc4­Cter failed to do so (Fig. 2 C).
Figure 3. Cdr2 hydrophobic 4–5 loop 
regulates clustering. (A) Localization of GFP-
tagged Cdr2-Cter, Cdr2-Cter mutated in the 
F residues of the 4–5 loop (Cdr2-CterFF*: 
F704D and F705D), or Cdr2-Cterbsc. Bar, 
5 µm. (bottom) 1.75× magnification of the 
boxed regions. Bar, 1 µm. (B) Fluorescence 
intensity along the cortex in regions boxed 
in A, representative of the cell population. 
(C) Pull-down assay between differentially 
tagged Cdr2-Cter, Cdr2-CterFF*, or Cdr2-
Cterbsc. Overexpressed GST–Cdr2-Cter, 
GST–Cdr2-CterFF*, or GST–Cdr2-Cterbsc were 
coupled to glutathione beads and mixed with 
extracts of cells expressing Cdr2-Cter–myc12, 
Cdr2-CterFF*–myc12, or Cdr2-Cterbsc*–myc12, 
respectively. Cdr2-Cter was revealed in input 
and pull-down fractions with anti-GST or anti-
myc antibodies. (right) Normalized Cter-myc 
signals in GST pull-down measured in three 
independent experiments. Molecular masses 
are indicated. Error bars show SDs. (D) Mean 
FRAP of mEGFP-tagged Cdr2 and Cdr2FF*  
mutant on the medial cortex as indicated. Error 
bars show SDs. Cdr2 t1/2 = 3 min; Cdr2FF* 
t1/2 < 1 min. (E) Localization of mEGFP-tagged 
Cdr2 or Cdr2FF*. Arrows show cell tip local-
ization of Cdr2FF*. Inverted black and white 
pictures are depicted. Bar, 5 µm. (right) Per-
centage of cells with Cdr2 or Cdr2FF* detected 
at cell tips. n > 80 cells. A.U., arbitrary unit; 
B, bleach; WB, Western blot.
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Cdr2­CterFF* was distributed evenly along the cortex (Fig. 3 A), 
suggesting that clustering is necessary to maintain a differential 
distribution between the medial cortex and the cell tips.
To confirm the specificity of these mutations on Cdr2­Cter 
oligomerization properties, Cdr2­CterFF* was next compared 
with Cdr2­Cterbsc, which lacks the basic region preceding the 
KA­1 domain. In this case, Cdr2­Cterbsc still formed clusters 
(Fig. 3, A and B), and similar to wild­type Cdr2­Cter, differ­
entially tagged Cdr2­Cterbsc mutants interacted in pull­down 
experiments (Fig. 3 C).
Finally, we introduced the mutations of hydrophobic resi­
dues of the 4–5 loop in full­length Cdr2 (Cdr2FF*). This led 
to fewer medial nodes and a small pool of the mutant protein 
at the cell tips (Figs. 3 E, 4 A, and S2 A). The mutations also 
resulted in a slightly increased cytoplasmic pool and increased 
dynamics on the cortex, consistent with a reduced clustering 
ability (Fig. 3, D and E). Combination of these mutations with 
mutations in the basic region preceding the KA­1 domain en­
hanced Cdr2 detachment from the cortex and confirmed that 
these two regions of Cdr2 cooperate to establish Cdr2 nodes at 
the cell medial cortex (Fig. S2 A).
In summary, Cdr2 KA­1 is not only essential for mem­
brane binding but also plays a role in Cdr2 clustering. Based on 
our homology modeling, this specific property of Cdr2 KA­1 
compared with Kcc4 KA­1 depends on a hydrophobic loop po­
sitioned on the surface opposite to that binding the membrane.
Because the mutations of F704 and F705 disrupted clus­
tering of Cdr2­Cter much more than it disrupted clustering of 
full­length Cdr2 (Fig. 3, A and E), we examined whether Cdr2 
sequences N terminal to Cdr2­Cter also contribute to Cdr2 node 
assembly. We constructed a Cdr2N­Kcc4C chimera, in which 
Cdr2­Cter (residues 591–775) was replaced by Kcc4­Cter (resi­
dues 917–1,037), to target the Cdr2 N terminus to the cortex. 
Whereas the Kcc4­Cter does not assemble into nodes on its own 
(Fig. 2 A), the Cdr2N­Kcc4C chimera formed nodes, though 
with much lower efficiency compared with full­length Cdr2 
(Fig. 4 A). Differentially tagged Cdr2N­Kcc4C chimeras could 
also interact with one another in immunoprecipitation experi­
ments, although the interactions were weaker than with full­
length Cdr2 molecules (Fig. 4 B). Thus, Cdr2 N­terminal 
regions exhibit clustering properties in addition to the C­terminal 
KA­1 domain.
We showed previously that Cdr2 associates with the 
anillin­like protein Mid1 in medial nodes (Almonacid 
et al., 2009; Moseley et al., 2009). Moreover, Mid1 can self­ 
interact, and a fragment that includes the Cdr2 interaction 
domain was recently reported to form octamers in vitro 
(Celton­Morizur et al., 2004; Almonacid et al., 2009; Saha and 
Pollard, 2012). We thus tested whether Mid1 could play a 
role in Cdr2 clustering and found that the clustering of Cdr2 
N terminus was dependent on interactions with Mid1, as 
Cdr2N­Kcc4C nodes were abolished in mid1400–450, which 
lacks the Cdr2 interaction site (Fig. 4 A). Node assembly was 
also largely disrupted when mid1400–450 was combined with 
the Cdr2FF* mutation, which was deficient for KA­1–dependent 
clustering (Fig. 4 A). In contrast, a control experiment showed that 
the clustering of Cdr2­Cter was maintained in the mid1400–450 
mutant (Fig. S2 B). We conclude that Cdr2 clustering relies 
on self­interactions of the C­terminal KA­1 domain and on 
N­terminal interactions with Mid1.
Figure 4. Mid1 contributes to Cdr2 N-terminal clustering. (A) Medial 
plane epifluorescence images of Cdr2-mEGFP, Cdr2N-Kcc4C–GFP chi-
mera, and Cdr2FF*-mEGFP in wild-type (wt) cells and mid1400–450 mutant 
deficient for Mid1 interaction with Cdr2. Bar, 5 µm. (B) Coimmunopre-
cipitation assays between mEGFP- and myc12-tagged Cdr2 or GFP- and 
myc12-tagged Cdr2N-Kcc4C. Immunoprecipitations were performed with 
anti-GFP mAb. Inputs and immunoprecipitation (IP) samples were probed 
with anti-GFP and anti-myc mAbs. Molecular masses are indicated. WB, 
Western blot.
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We reasoned that to prevent node assembly, Pom1 may 
regulate Cdr2 interaction with the cortex through modulation 
of Cdr2 membrane binding and/or clustering. To test this, we 
expressed a Pom1C­Mid1C chimera (called Pom1­chimera 
hereafter) in which the Mid1 C­terminal amphipathic helix tar­
gets Pom1 kinase domain to the medial cortex independently 
of Cdr2 (Celton­Morizur et al., 2004; Almonacid et al., 2009). 
This construct was previously shown to induce Cdr2 redistribu­
tion on the cortex and to delay mitotic entry (Moseley et al., 
2009), demonstrating that the Pom1 kinase domain is active. 
We found that the expression of Pom1­chimera strongly in­
creased Cdr2 dynamics on the cortex as measured by FRAP 
(Fig. 5, C, F, and G).
In contrast, we did not detect significant changes in Cdr2 
exchange rate on the medial cortex upon pom1 deletion (Fig. 5 D). 
In these cells, Cdr2 was detected in the nongrowing cell tip re­
gion as expected (Fig. 5 E; Martin, 2009; Moseley et al., 2009). 
Pom1 modulates Cdr2 dynamics  
on the cortex
We next analyzed how Pom1 controls Cdr2 node distribution 
on the cortex by comparing quantitatively the number and dis­
tribution of nodes in wild­type cells and in pom1 cells, which 
grow in a monopolar fashion with Cdr2 nodes invading the 
nongrowing cell tip (Bähler and Pringle, 1998; Martin and 
Berthelot­Grosjean, 2009; Moseley et al., 2009). We found 
that in pom1 cells, the Cdr2 domain spanned approximately 
two thirds of the cell length compared with approximately 
one third in wild­type, from cell birth through cell division 
(Fig. 5, A and E). Moreover, the number of nodes was signifi­
cantly increased in pom1 cells (Fig. 5, B and E). This sug­
gested that Pom1 may prevent node assembly in cell tip 
regions, where it is most concentrated, in parallel with cell 
growth, which restricts nodes from growing regions indepen­
dently of Pom1 by an unknown mechanism.
Figure 5. Pom1 controls Cdr2 node assembly 
by modulation of its dynamic exchange on the 
cortex. (A) Length of the domain occupied by 
Cdr2-mEGFP nodes in the medial focal plane 
relative to cell length in wild-type (n = 105) 
and pom1 cells (n = 296). (B) Number of 
Cdr2-mEGFP nodes in the medial focal plane 
relative to cell length in wild-type and pom1 
cells. (C and D) Mean FRAP of Cdr2-mEGFP 
on the medial cortex in wild-type cells and cells 
expressing Pom1-chimera (C) or in wild-type 
and pom1 cells (D). Error bars show SDs. 
Cdr2 t1/2 in C: pom1+ t1/2 > 90 s; pom1- 
chimera = 15 s < t1/2 < 30 s. Cdr2 t1/2 in D: 
pom1+ t1/2 = 3 min; pom1 t1/2 = 3 min. 
(E) Cdr2-GFP localization in wild-type and 
pom1 cells and in wild-type cells express-
ing Pom1-chimera. (F) Example of FRAP of 
Cdr2-mEGFP on the medial cortex in a wild-
type cell. The bleached regions are boxed. 
(G) Example of FRAP of Cdr2-mEGFP on the 
medial cortex in a cell expressing Pom1-chi-
mera. The bleached regions are boxed. P, pre-
bleach; B, bleach. Bars, 4 µm.
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2009; Moseley et al., 2009). In addition, Cdr2­Cter was more 
enriched at both tips upon expression of Pom1­chimera. Cdr2­
Cter clustering was not affected in these conditions. Finally, de­
letion of the Cdr2­Cter basic motif also induced a redistribution 
of Cdr2­Cter toward the cell tips, suggesting that this basic motif 
could be a Pom1 target.
Proteomic analysis of phosphopeptides from Cdr2­mEGFP 
immunoprecipitated from wild­type cells revealed four sites 
phosphorylated in vivo within the Cdr2­Cter basic motif (S604, 
S607, S616, and S618; Figs. 7 C and S4 A). In addition, recom­
binant GST­Pom1 phosphorylated a maltose­binding protein 
(MBP)–Cdr2 fragment comprising the Cdr2­Cter basic motif 
(aa 518–620) in vitro (Figs. 7 D and S4 B). Mutation of these 
four sites to nonphosphorylatable residues (Cdr2bsc­4A) reduced 
32P incorporation (shorter Cdr2 fragments within this region 
could not be tested as substrates as they were unfortunately un­
stable or insoluble; Figs. 7 D and S4 B). These results suggest 
that the four sites represent some of the Pom1 phosphosites on 
Cdr2, although other as­yet­unidentified phosphosites may also 
be targeted by Pom1 in vitro.
Substitution of S618 by aspartic acid, alanine, or arginine 
in Cdr2 expressed from its endogenous locus led to cell elonga­
tion at division in all cases (unpublished data), suggesting that 
mutations of this amino acid may unfold the region and alter 
Cdr2 interaction with the cortex nonspecifically, precluding a 
functional interpretation of these results. We therefore produced 
a triple substitution of serines 604, 607, and 616 to aspartic acid 
(Cdr2­Cterbsc­3D and Cdr2bsc­3D mutants) to mimic phosphoryla­
tion or to alanine to inhibit phosphorylation (Cdr2­Cterbsc­3A and 
Cdr2bsc­3A mutants). These mutations affected the cortical distri­
bution of Cdr2­Cter only mildly (Figs. 7 E and 8 A). Neverthe­
less, intensity measurements revealed that Cdr2­Cterbsc­3D and 
Cdr2­Cterbsc­3A were less concentrated in the medial region com­
pared with cell tips (Fig. 7 F). The localization of full­length 
Cdr2bsc­3D and Cdr2bsc­3A mutants was largely similar to wild­type 
Cdr2, although a small pool of these mutants could be detected 
at the cell tips in 40% of cells (Fig. S5 A). FRAP analysis also 
revealed faster exchange rates for Cdr2bsc­3D on the cortex com­
pared with wild­type Cdr2 (Fig. S5 B). In contrast, exchange 
rates were slightly slower when serines 604, 607, and 616 were 
converted to basic residues (Cdr2bsc­3R; Fig. S5 B). This con­
firms that the basic region establishes electrostatic interactions 
with acidic phospholipids of the plasma membrane that can be 
negatively modulated by negative charges mimicking phos­
phorylation or artificially enhanced by addition of basic resi­
dues. Collectively, these results suggest that the Cdr2 C­terminal 
basic motif, adjacent to the KA­1 domain, is a direct target of 
Pom1 to modulate Cdr2 affinity for acidic phospholipids of the 
plasma membrane.
Combining mutations in the basic regions 
with inhibition of N-terminal clustering 
recapitulates Pom1 regulation
As described thus far, the two relatively mild effects of Pom1 
on Cdr2 (effect on clustering mediated through the Cdr2 
N­terminal region and effect on membrane binding involving 
the C­terminal basic motif adjacent to the KA­1 domain) are 
We measured slightly faster exchange rates at nongrowing cell 
tips than on the medial cortex (Fig. S3 A).
We conclude that Pom1 may normally restrict Cdr2 nodes 
to the medial cortex by increasing Cdr2 dynamic exchange at 
the cell tips, thereby restricting node assembly to the cell middle 
where Cdr2 can associate more stably with the cortex. Pom1­ 
independent factors could also contribute to a minor extent to 
the differential regulation of Cdr2 exchange on the cortex be­
tween nongrowing cell tips and the cell middle.
Pom1 down-regulates Cdr2 clustering by 
modulation of Cdr2–Mid1 interaction
To increase Cdr2 turnover on the cortex, Pom1 could reduce 
Cdr2 affinity for the plasma membrane or down­regulate its 
clustering properties. Using the Pom1­chimera, we first tested 
a possible effect of Pom1 on Cdr2 N­terminal clustering. 
Strikingly, neither Cdr2N­Kcc4C chimera nor Cdr2FF* mutant 
formed nodes in the presence of Pom1­chimera and redistrib­
uted toward the cell tips in a smoother pattern (Figs. 6 A and 
S3 C). We also found after careful quantification that Pom1­
chimera reduced by 50% the level of Mid1 coimmunopre­
cipitation with Cdr2N­Kcc4C (Fig. 6 B) and by 25% the 
degree of colocalization between Cdr2 and Mid1 nodes at the 
medial cortex (Fig. 6 C). In contrast, the degree of colocal­
ization between Cdr2 and Mid1 nodes remained similar upon 
pom1 deletion (Fig. S3 B). Together, these results indicate 
that Pom1 negatively regulates the Mid1­dependent clustering 
of Cdr2 N terminus.
It has been shown that Cdr2 association with Mid1 par­
tially depends on Cdr2 kinase activity (Almonacid et al., 2009; 
Moseley et al., 2009). Accordingly, we found that disrupting 
Cdr2 kinase activity by introduction of a kinase­dead mutation 
(E177A referred to as Cdr2KD; Morrell et al., 2004) abolished 
Cdr2N­Kcc4C node formation (Fig. 6 A). A similar result was 
obtained with the Cdr2FF* mutant (Fig. S3 C). Disrupting Cdr2 
kinase activity also reduced both Mid1 coimmunoprecipitation 
with Cdr2N­Kcc4C chimera and the degree of Mid1 colocaliza­
tion with Cdr2 cortical nodes, mimicking the effect of Pom1 
(Fig. 6, B and C).
In contrast, as reported previously (Almonacid et al., 2009; 
Moseley et al., 2009), Cdr2KD mutation alone or in combina­
tion with mid1400–450 was neither sufficient to affect node 
formation by full­length Cdr2 nor to mimic Pom1­chimera 
effect on its dynamic exchange on the cortex (Figs. 6 A and S3, 
D and E). Thus, inhibiting the Mid1­dependent clustering of the 
Cdr2 N terminus is not sufficient to recapitulate Pom1 effect on 
Cdr2. This indicates that Pom1 may regulate additional proper­
ties of Cdr2 besides Mid1­dependent clustering.
Pom1 phosphorylates Cdr2 C-terminal  
basic motif
We thus tested whether Pom1 also acts on the Cdr2 C terminus 
(Fig. 7, A and B). Analysis of Cdr2­Cter distribution on the cor­
tex revealed that it was largely excluded from both cell tips in 
most wild­type cells but enriched at one or both cell tips in the 
majority of pom1 cells, reminiscent of the localization of full­
length Cdr2 in pom1 cells (Martin and Berthelot­Grosjean, 
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individually insufficient to promote Cdr2 node disassembly. We 
thus tested next whether their combination could recapitulate 
Pom1 inhibition of node assembly. To do so, we produced a double 
cdr2bsc-3D mid1400–450 mutant to mimic the dual regulation per­
formed by Pom1. In this context, Cdr2 node assembly was strongly 
affected specifically in the number of nodes (Fig. 8, A and B). 
Figure 6. Cdr2 N-terminal clustering is under the con-
trol of Pom1 and Cdr2 kinase activity. (A) Medial plane 
epifluorescence images of Cdr2-mEGFP and Cdr2N-
Kcc4C–GFP chimera in wild-type (wt) cells or cells ex-
pressing Pom1-chimera or carrying a Cdr2 kinase-dead 
mutation (KD; E177A). (B) Coimmunoprecipitation 
assays between Cdr2N-Kcc4C–GFP and Mid1 in wild-
type cells and cells expressing the Pom1-chimera or 
Cdr2NKD-Kcc4–GFP and Mid1. Immunoprecipitations 
were performed with anti-GFP mAb. Inputs and immuno-
precipitation (IP) samples were probed with anti-GFP 
mAb and anti-Mid1 affinity-purified antibody. Mean 
normalized Mid1 coimmunoprecipitation signals from 
four independent experiments are shown on the right. 
Error bars show SDs. Molecular masses are indicated. 
(C, top) Medial plane confocal images of Mid1-mEGFP 
and Cdr2-TagRFP in wild-type cells (left) and cells ex-
pressing the Pom1-chimera (center) or of Mid1-mEGFP 
and Cdr2KD-TagRFP (right). (bottom) Mid1-mEGFP and 
Cdr2-TagRFP intensity along the medial cortex in the 
same cell. (bottom right) Mean percentage of Cdr2-
TagRFP nodes containing Mid1-mEGFP in individual 
cells. Error bars show SDs (n ≥ 25 cells). WB, Western 
blot. Bars, 5 µm.
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Figure 7. Pom1 phosphorylates the Cdr2 C-terminal basic domain to modulate Cdr2 association with membranes. (A) Localization of GFP–Cdr2-Cter in 
wild-type (wt) and pom1 cells or in cells expressing the Pom1-chimera and of GFP–Cdr2-Cterbsc in wild-type cells. (B) GFP–Cdr2-Cter fluorescence inten-
sity ratio between the cell tip and the medial cortex in strains shown in A: Cdr2-Cter (n = 31), Cdr2-Cter pom1 (n = 39), Cdr2-Cter Pom1-chimera (n = 37), 
and Cdr2-Cterbsc (n = 34) from two experiments. T1, tip of lowest intensity; T2, tip of highest intensity. Horizontal bars are means. (C) Scheme highlighting 
the sequence of Cdr2 basic domain and residues found to be phosphorylated in vivo (red). (D) In vitro kinase assay of GST-Pom1 on MBP-Cdr2(518–620) 
with the indicated mutations. (top) Phosphorimager detection of 32P incorporation. (bottom) Silver-stained gel. The top band represents Pom1 autophos-
phorylation. Molecular masses are indicated. Black bars indicate that intervening lanes have been spliced out. (E) Localization of GFP–Cdr2-Cterbsc-3D 
(S604D, S607D, and S616D) or GFP–Cdr2-Cterbsc-3A (S604A, S607A, and S616A). (F) GFP–Cdr2-Cter fluorescence intensity ratio between the cell tip and 
the medial cortex in strains shown in E. Cdr2-Cter (n = 45), Cterbsc-3D (n = 39), and Cterbsc-3A (n = 44) from one experiment representative of two repeats. 
Horizontal bars are means. Gray bars represent t tests: *, P < 5 × 102; **, P < 5 × 103. Bars, 5 µm.
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pom1 cells. Because Cdr2­dependent positioning of Mid1 
is corrected by Mid1 export from the nucleus at mitotic entry 
(Almonacid et al., 2009), we combined the cdr2bsc-3A mutation 
with the mid1nsm mutation preventing Mid1 shuttling in the nu­
cleus (Almonacid et al., 2009). Measuring septum position, we 
In contrast, combining cdr2bsc-3A with mid1400–450 did not impair 
node assembly. Similar results were obtained when cdr2bsc-3D or 
cdr2bsc-3A was combined to the cdr2KD mutation (Fig. 8, A and B).
We finally tested whether the cdr2bsc-3A mutant presented 
functional defects in division plane positioning similar to 
Figure 8. Combined modulations of mem-
brane anchoring and N-terminal clustering 
strongly affect Cdr2 node assembly. (A) Lo-
calization of mEGFP-tagged Cdr2, Cdr2bsc-3D, 
and Cdr2bsc-3A in wild-type and mid1400–450 
cells or when Cdr2 also carries the E177A ki-
nase-dead mutation (KD). (B) Number of nodes 
in the medial focal plane relative to cell length 
in similar cells as in A. Error bars show SDs. 
(C) Differential interference contrast images 
of mid1nsm or cdr2bsc-3A mid1nsm cells (left) and 
asymmetric positioning of the division plane 
measured as a ratio between the distance be-
tween septum and closest cell tip over total cell 
length in mid1nsm (n = 48), cdr2bsc-3A (n = 53), 
cdr2bsc-3A mid1nsm (n = 53), and pom1 cells 
(n = 64) from one experiment out of three 
repeats (right). Asterisks show cells with an 
asymmetrically positioned septum. Horizon-
tal bars are means. t tests: *, P < 5 × 102; 
***, P < 105. Bars, 5 µm.
 o
n
 July 7, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published June 30, 2014
JCB • VOLUME 206 • NUMBER 1 • 2014 72
that the total number of cortical nodes and the width of their 
distribution must remain in a narrow range for an efficient as­
sembly process.
Cdr2 has been shown to be the major node scaffolding 
component, which initiates node assembly during interphase 
(Almonacid et al., 2009; Moseley et al., 2009). Nevertheless, 
how Cdr2 controls node assembly and how the Pom1 gradients 
function to influence node distribution and limit node number 
and node spreading to a narrow region of the medial cortex have 
remained unclear. In this work, we established some of the key 
molecular properties by which Cdr2 can assemble into cortical 
nodes and deciphered molecular mechanisms of Pom1­dependent 
control of node assembly.
Cdr2 membrane binding and clustering 
properties drive node assembly
Cdr2 ability to assemble into cortical nodes relies on (a) Cdr2 
membrane binding properties and (b) Cdr2 propensity to as­
semble into clusters of molecules. Membrane binding is ensured 
primarily by a C­terminal lipid­binding KA­1 domain, which 
functions similarly to Kcc4 KA­1 (Moravcevic et al., 2010) and 
may bind to phosphatidylserine, an abundant acidic phospho­
lipid of the inner leaflet of the plasma membrane. Accordingly, 
using a model of Cdr2 KA­1 based on Kcc4 crystal structure, 
we could show that Cdr2 KA­1 possesses several likely surface­
exposed basic residues that are required for Cdr2 targeting to 
the cortex and likely establish electrostatic interactions with 
acidic phospholipids of the plasma membrane.
Membrane binding of Cdr2 is reinforced by a basic motif 
that lies a few residues before Cdr2 KA­1 along the Cdr2 se­
quence. This motif is of particular interest, as we found that it 
constitutes a modulator of Cdr2 membrane binding affinity that 
is targeted by Pom1 kinase (see Pom1 controls Cdr2 node as­
sembly and distribution in Discussion).
Cdr2 clustering depends on a dual mechanism. It involves 
primarily Cdr2 KA­1. This additional and unique clustering prop­
erty of Cdr2 KA­1 compared with previously characterized KA­
1s (Moravcevic et al., 2010) involves the hydrophobic 4–5 
loop containing two phenylalanine residues, not conserved in 
Kcc4 KA­1 and located opposite to the putative membrane 
binding surface in the Cdr2 KA­1 model. Additional work will 
be necessary to establish how this loop confers oligomeriza­
tion properties to Cdr2 KA­1. Interestingly, this feature of Cdr2 
KA­1 may be shared with other fission yeast species and other 
filamentous fungi because the 4–5 loop of Cdr2 orthologues 
in Schizosaccharomyces japonicus or Aspergillus nidulans also 
contain hydrophobic residues (unpublished data).
The second mechanism of clustering depends on Cdr2 
N­terminal region and requires Mid1. This result was unexpected 
because Cdr2 was previously shown to assemble into nodes in 
the absence of Mid1 or when Mid1 cannot interact with Cdr2 
(Mid1400–450 mutant; Almonacid et al., 2009; Moseley et al., 
2009). Indeed, the Mid1–Cdr2 interaction was shown to recruit 
Mid1 to Cdr2 nodes (Almonacid et al., 2009; Moseley et al., 
2009). Our results now show it also contributes to reinforcing 
these nodes through Cdr2 clustering, in addition to the KA­1 
domain. Clustering mediated by a partner protein is reminiscent 
found that the double mutant divided more asymmetrically than 
either single mutant (Fig. 8 C), although the degree of asymme­
try was less pronounced than in pom1 cells. We conclude that 
the cdr2bsc-3A mutant exhibits some Pom1­resistant properties 
for division plane positioning.
We conclude that Pom1 restricts Cdr2 node assembly to 
the cell middle by a dual modulation of its clustering and affin­
ity for membrane lipids. The fact that similar effects are elicited 
by preventing Mid1­dependent clustering of the Cdr2 N terminus 
and by inhibition of Cdr2 kinase activity suggests that the 
Pom1 effect on Cdr2 clustering could possibly rely on the down­
regulation of Cdr2 kinase activity (Fig. 9).
Discussion
Fission yeast assembles its cytokinetic contractile ring in two 
major steps: first, by recruitment of ring components on precur­
sors nodes in a medial region of the cortex and second, by com­
paction of mature nodes into a tight and well­centered ring. 
Such a mechanism may be evolutionarily conserved because 
two genetically independent steps of assembly have also been 
described in Caenorhabditis elegans (Lewellyn et al., 2010).
A key feature of this assembly mechanism is that precursor 
nodes are heterooligomeric assemblies of membrane­binding 
proteins. A detailed description of the composition and number 
of molecules present in these nodes before and after their mi­
totic maturation has been obtained (Wu et al., 2003; Wu and 
Pollard, 2005; Almonacid et al., 2009; Laporte et al., 2011; 
Akamatsu et al., 2014), and node motion studies combined with 
mathematical modeling have revealed that transient actomyo­
sin­dependent attraction forces between nodes can promote 
their compaction into a functional ring with the contribution of 
F­actin–bundling proteins (Vavylonis et al., 2008; Ojkic et al., 
2011; Laporte et al., 2012). In particular, modeling highlighted 
Figure 9. Model for Pom1-dependent regulation of Cdr2 node assembly 
to restrict Cdr2 nodes to the medial cortex. Cdr2 binding to the plasma 
membrane depends on Cdr2 C terminus containing a KA-1 domain and 
basic motif that establish electrostatic interaction with acidic phospholipids 
such as phosphatidylserine. Cdr2 clustering relies on a unique property of 
Cdr2 KA-1 domain involving the hydrophobic loop (FF) as well as on Cdr2 
N-terminal region in a Mid1-dependent manner. Pom1 prevents node as-
sembly at the cell tips by phosphorylating the basic motif, reducing its 
affinity for lipids, and by modulating the Cdr2 N-terminal interaction with 
Mid1 involved in clustering. This second regulation exerted by Pom1 could 
result indirectly from an inhibition of Cdr2 activity by Pom1 kinase. Cter, 
C terminus; P, phosphorylation.
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mild effects on membrane binding and clustering, Pom1 renders 
Cdr2 node assembly less favorable at the cell tips compared with 
other regions of the cortex, leading to accumulation of stable 
nodes at the cell middle. The Cdr2 clustering properties may fur­
ther reinforce this localization by increasing the avidity of Cdr2 
molecules for regions with established nodes compared with Cdr2­
free regions of the cortex, thus creating a positive feedback fo­
cusing the concentration of Cdr2 on the medial cortex.
We note that the assembly of Cdr2 nodes is not fully abol­
ished upon modulation of Cdr2 membrane binding and Mid1­
dependent clustering. It is thus possible that Pom1 has additional 
effects on Cdr2, through as­yet­unidentified phosphorylation 
sites or on Cdr2 partners within medial cortical nodes (e.g., 
Mid1, Blt1, or Gef2) to further inhibit node assembly.
Additional factors are also likely to contribute to Cdr2 node 
spatial restriction to the cell middle besides Pom1. Indeed, it is well 
established that in the absence of Pom1, Cdr2 node distribution 
depends on the cell’s growth pattern (Martin and Berthelot­Grosjean, 
2009; Moseley et al., 2009), though how growth prevents Cdr2 
node assembly remains elusive. Possible factors contributing to 
Cdr2 exclusion from growing cell tips include lipid microdomains, 
sterol­rich microdomains in particular because they are enriched at 
cell tips (Wachtler et al., 2003), and filipin treatment was shown to 
disrupt Cdr2 nodes (Morrell et al., 2004). Interestingly, in pom1 
cells, the Cdr2 domain, which spans approximately two thirds of 
the cell length, keeps enlarging with cell length, indicating that 
Cdr2 domain enlargement with cell size may be largely driven by 
cell extension. This growth pattern–dependent control may thus 
further reinforce Cdr2 medial localization, in addition to the 
Pom1­dependent mechanisms described here.
Finally, the presence of Cdr2 at the cell cortex is impor­
tant not only for division plane positioning but also for the 
timing of cell division (Morrell et al., 2004; Martin and Berthelot­
Grosjean, 2009; Moseley et al., 2009). Accordingly, we found 
that mutants with important cortex anchoring defects displayed 
a longer cell size at division, suggesting that minimum amounts 
of cortical Cdr2 are necessary for timely entry in mitosis. Nev­
ertheless, we also showed recently that a 50% reduction of Cdr2 
amounts does not modify cell length at division in diploids, 
whereas mild overexpression of Cdr2 in haploids strongly ad­
vances mitosis only if pom1 is deleted (Bhatia et al., 2014). 
These data indicate that mitotic commitment is fairly robust to 
alterations in Cdr2 levels when Cdr2 activity is under Pom1 
control. Thus, the Pom1­dependent regulation of Cdr2 node as­
sembly described here may primarily serve as an input for divi­
sion plane placement, whereas the timing of cell division is 
modulated by Pom1­dependent regulation of Cdr2 kinase activ­
ity (Bhatia et al., 2014; Deng et al., 2014).
In conclusion, our work provides a first mechanistic 
model for how Pom1 gradients can delineate the medial re­
gion of the cell where Cdr2 cooperates with Mid1 to assemble 
precursor nodes for the actomyosin ring to determine the po­
sition of the division plane accurately and robustly and favor 
the production of equally sized daughter cells. This model may 
be conceptually relevant to spatial regulatory events involving 
membrane­based gradients during cell polarity establishment in 
other eukaryotes.
of the reported septin­dependent clustering of Kcc4 at the bud 
neck (Moravcevic et al., 2010) and may rely on Mid1 oligomer­
ization properties (Celton­Morizur et al., 2004; Saha and Pollard, 
2012). Because the Mid1–Cdr2 interaction is reinforced by Blt1 
and Gef2 (Guzman­Vendrell et al., 2013), these components of 
medial cortical nodes may also contribute to Cdr2 clustering. 
Similar to the nonessential membrane­binding basic motif, 
Mid1­dependent Cdr2 clustering is of particular physiological 
interest because it can be modulated by Pom1 (see next section).
Pom1 controls Cdr2 node assembly  
and distribution
Our work shows that Pom1 controls the distribution of Cdr2 
nodes in two distinct ways: modulation of Cdr2 membrane bind­
ing and modulation of Mid1­dependent clustering (Fig. 9). Mass 
spectrometry (MS) and in vitro phosphorylation experiments 
identified four phosphorylation sites within the Cdr2 basic motif. 
Among them, S604 but not the others, matches the R­(X)1–3­S/T­
P/V/L DYRK2 consensus. However, we note that DYRK kinases 
phosphosites are sometimes loosely related to the consensus, in 
particular Pom1 autophosphorylation sites identified from bacte­
rially expressed Pom1 (Campbell and Proud, 2002; Aranda et al., 
2011; Hachet et al., 2011). Functional analysis showed Pom1­
dependent phosphorylations on the C­terminal basic motif increase 
slightly Cdr2 exchange rate on the cortex without important 
effect on node assembly on their own.
Whereas Pom1 does not appear to modulate the unique 
clustering properties of Cdr2 KA­1 domain, we found that it 
acts on Mid1­dependent clustering of Cdr2 in addition to the 
aforementioned modulation of Cdr2 affinity for lipids. Thus, 
Mid1, which represents the physiological target of Pom1­ 
dependent spatial regulation of Cdr2 nodes for division plane 
positioning, appears to contribute to its own spatial regulation 
rather than bind passively to Cdr2 nodes prepositioned in the 
cell middle by Pom1.
It is interesting that the effect of Pom1 on Mid1­dependent 
clustering of Cdr2 can be mimicked by a down­regulation of 
Cdr2 kinase activity, which has been shown to modulate Mid1 
recruitment to Cdr2 nodes (Almonacid et al., 2009; Moseley 
et al., 2009). It is thus possible that Pom1 controls Cdr2 clustering 
by modulating its activity. One recently proposed mechanism by 
which Pom1 may inhibit Cdr2 activity, without a noted effect on 
Cdr2 node localization or assembly, involves Pom1­dependent 
phosphorylation of the short C­terminal tail of Cdr2 after the KA­1 
domain (Bhatia et al., 2014; Deng et al., 2014). This phosphoryla­
tion was shown to antagonize the phosphorylation of Cdr2 T loop 
by the calcium/calmodulin­dependent protein kinase kinase 
Ssp1, necessary for the activation of Cdr2 (Deng et al., 2014).
However, this C­terminal tail phosphorylated by Pom1 is 
absent in the Cdr2N­Kcc4–KA­1 chimera used to establish that 
Pom1 regulates Mid1­dependent clustering of Cdr2. Future ex­
periments will thus be necessary to address if and how Pom1 con­
trols Cdr2 kinase activity independently of the C­terminal tail.
Although neither of the two additional effects exerted by 
Pom1 on Cdr2 that we describe here is sufficient on its own, we 
show that mimicking them simultaneously strongly reduces the 
efficiency of node assembly. We propose that, by combining two 
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XhoI in a pMAL–tobacco etch virus (TEV) vector, respectively, and used for 
recombinant protein production and kinase assays. A list of the plasmids 
used in the study can be found in Table S2.
Microscopy and image analysis
For epifluorescence images shown in Figs. 1 C, S1 A, 2 A, S2, 3 A, S3 C, 
4 A, 6 A, and 8 A or transmission images in Fig. 8 C and spinning-disc 
confocal images shown in Figs. S3 (B and D), 5 (E–G), 6 C, and 7 (A and E), 
cells were grown at 25°C in YE5S. Epifluorescence images were taken 
on an upright microscope (DMRXA2; Leica) controlled with MetaMorph 
software 7.7.8 (Molecular Devices) and equipped with a 100×, 1.4 NA 
oil immersion Plan Apochromat objective and a charge-coupled device 
camera (CoolSNAP HQ2; Photometrics) with an exposure time of 2 s. 
Confocal images were taken on a fully motorized inverted microscope 
(Eclipse Ti-E; Nikon) controlled with MetaMorph software 7.7.8 and 
equipped with the Perfect Focus System (Nikon) to maintain the focus, a 
100×, 1.45 NA Plan Apochromat oil immersion objective, a piezo stage 
(Mad City Labs), a confocal unit (CSUX1; Yokogawa Corporation of Amer-
ica), a charge-coupled device camera (CoolSNAP HQ2), and a laser 
bench (Errol) with a 491–561-nm diode laser (100 mW each; Cobolt). Ex-
posure time for GFP, mCherry, or tdTomato was 2 s (or 0.5 s for Fig. S3 D). 
Laser power was 30% (back pupil of the objective: 1.9 mW), binning was 
set at 2, and electronic gain was set to 3. All images were scaled similarly 
to their respective control using MetaMorph software 7.7.8.
FRAP experiments of Figs. 1 D, 3 D, 5 (C and D), S3 E, and S5 
were performed on the Eclipse spinning-disk setup. The FRAP module was 
controlled by iLas software (Roper Scientific) integrated to MetaMorph soft-
ware 7.7.8. Medial cortex regions of 30 × 5 pixels (3.7 µm long) were 
bleached for 200 ms at 100% laser power (back pupil of the objective: 8.1 
mW), after five image acquisitions at 1-s intervals. Postbleach images were 
acquired every 60 s (or 15 s in Fig. 5 C) over a 20-min period and were 
exposed over 0.5 s at 30% laser power, binning at 2, and electronic gain 
at 3 (for a 5-min period in Fig. 5 C). For fluorescence recovery analysis, 
images were first registered with the ImageJ plugin StackReg (National 
Institutes of Health) and analyzed with MetaMorph software 7.7.8. In brief, 
bleaching correction was performed by calculating the mean Cdr2 intensity 
decay along the acquisition of at least five nonbleached cells. Bleaching 
correction was individually applied to each bleached region. Bleaching 
recovery curves were then normalized with the first point after bleaching cor-
responding to 0% and the first point before bleaching corresponding to 
100% and averaged. t1/2’s were estimated graphically as the time point 
after bleaching when half-maximum recovery was reached. Maximum re-
covery was defined as the mean intensity of the last four data points.
Analysis of Cdr2-mEGFP domain length and node number shown in 
Fig. 5 (A and B) was performed on epifluorescence images. In Figs. 6 C and 
S3 B, Mid1-mEGFP and Cdr2-TagRFP cortical fluorescence intensity was 
measured along a 100-pixel-long line on the medial cortex with the Linescan 
tool of MetaMorph software 7.7.8 (3 pixel width) on single medial focal 
planes. The percentage of Cdr2 nodes containing Mid1 was derived from 
these line scans as the percentage of Cdr2 peaks that coincided with a Mid1 
peak. Similarly, for Fig. 7 (B and F), fluorescence intensity of GFP–Cdr2-Cter 
was recorded along a 40-pixel-long line on the cell tip and medial cortex, 
and the intensity ratio was calculated after background deduction.
For cell length measurements, cells were grown at 30°C in Edinburgh 
minimal medium supplemented with uracil, adenine, and leucine. Cell 
length measurements were made with MetaMorph software on differential 
interference contrast images of septating cells taken on the DMRXA2 micro-
scope described previously in this section. In all comparisons made, strains 
with identical auxotrophies were used.
Cdr2 KA-1 3D homology modeling
3D homology modeling was performed according to Šali and Blundell 
(1993) using the Modeler 9.0 in the DS Modeling 1.7 software package 
(Accelrys). The model for Cdr2 KA-1 was generated by using the coordi-
nates of Kcc4 KA-1 (Protein Data Bank accession no. 3OSM). The struc-
tural quality of the models was assessed according to the Modeler 
probability density functions as well as Profiles-3D analysis (DS Modeling 
1.7). Out of the 10 models generated, the one with the lowest energy was 
selected. 3D molecular representations were obtained by using PyMOL 
(DeLano Scientific LLC).
Analysis of phosphorylation sites by MS
For MS analysis, Cdr2-GFP was purified from extracts of nonsynchronous 
cells using anti-GFP mAb (Roche) as previously described (Almonacid et al., 
2011). After immunoprecipitation, proteins were submitted to SDS-PAGE 
Materials and methods
Yeast genetics and culture
Standard S. pombe media and genetic manipulations were used (Moreno 
et al., 1991). All strains used in the study were isogenic to wild-type 972 
and are described in Table S1. Strains from genetic crosses were selected 
by random spore germination or tetrad dissection and replica in plates 
with appropriate supplements or drugs. Transformations were performed 
using the lithium acetate–DMSO method as previously described (Bähler 
et al., 1998).
Production of mutant and tagged strains
Cdr2 deletion strain, a gift from J. Moseley (Geisel School of Medicine, 
Dartmouth College, Hanover, NH; Moseley et al., 2009) was produced by 
homologous recombination using the pFa6a-NatMX6 plasmid (Hentges 
et al., 2005) as previously described (Bähler et al., 1998). All cdr2 mutant 
alleles were integrated at the cdr2 endogenous locus, except those cloned 
in pJK148- or pJK210-derived plasmids, as detailed in Table S1. These 
constructs were, respectively, integrated at the leu1 and ura4 locus under 
the control of their own promoter unless stated otherwise.
Mutants of Cdr2 KA-1 domain, basic region, or Cdr2 kinase-dead 
mutant (Cdr2KD carrying the E177A substitution) were produced by site-
directed mutagenesis of pSR3, a pBluescript plasmid carrying Cdr2 ORF, 
or by double PCR. Most mutants were then subcloned between BamHI 
and PacI sites in pSR34 (Guzman-Vendrell et al., 2013), a pFA6a-mEGFP-
KanMX6–derived plasmid carrying cdr2 promoter and terminator for in-
tegration at cdr2 locus in a cdr2::NatMX6 strain, in replacement of the 
NatMX6 cassette by homologous recombination. Plasmids were digested 
with NotI before transformation.
Cdr2N-Kcc4C and Cdr2NKD-Kcc4C chimeras containing Cdr2 resi-
dues 1–590 and Kcc4 residues 917–1,037, C-terminally tagged with 
GFP, were inserted between BamHI and AscI sites of pSR34. Plasmids 
were digested with SpeI before transformation.
The sequence encoding Cdr2-Cter (residues 591–747) N-terminally 
tagged with GFP, carrying or not carrying mutations (FF*, bsc, bsc-3D, 
and bsc-3A), was cloned between PacI and AscI sites in pSR25. GFP–
Kcc4-Cter (residues 893–1,037) was cloned in pSR25 between BamHI 
and AscI sites.
Cdr2hlx1*, Cdr2hlx2*, and Cdr2hlx3* mutants C-terminally tagged with 
GFP were cloned between XhoI and SalI sites in a pJK148-derived plasmid 
(Keeney and Boeke, 1994) containing cdr2 promoter and nmt1 termina-
tor. Plasmids were digested with NruI before transformation.
Cdr2, Cdr2-Cter, Cdr2-Cterbsc, Cdr2-CterFF*, and Kcc4-Cter were 
also cloned between XhoI and NotI sites in a pJK148 plasmid containing 
the cdr2 promoter, a C-terminal myc12 tag derived from pINV-myc (Iacovoni 
et al., 1999), and the nmt1 terminator. Plasmids were digested with NruI 
before transformation.
Cdr2N-Kcc4C chimera was subcloned between XhoI and NotI sites 
in a pJK210-derived plasmid (Keeney and Boeke, 1994) containing the 
cdr2 promoter, a C-terminal myc12 tag, and the nmt1 terminator. This plas-
mid was digested with StuI before transformation.
To produce a Cdr2-TagRFP strain, TagRFP was amplified by PCR from 
pTagRFP-N (Evrogen) and cloned between PacI and AscI sites in pFa6a-
GFP::NatMX6 (Hentges et al., 2005) in replacement of GFP to obtain the 
pFa6a-TagRFP::NatMX6. This plasmid was used to integrate TagRFP in the 
C terminus of Cdr2 at the endogenous locus (Bähler et al., 1998).
Pom1-chimera, previously referred to as PMT (plasma membrane 
targeting)-Pom1C chimera, was expressed from a construct derived from the 
pAM18 plasmid, integrated at leu1 locus by homologous recombination 
(Moseley et al., 2009). This construct encodes amino acids 500–920 of 
Mid1 in fusion with amino acids 591–1,087 of Pom1 and mCherry under 
the control of mid1 promoter. To produce Pom1-chimera–HA3, the mCherry 
tag from pAM18 (Moseley et al., 2009) was exchanged by an HA3 epit-
ope. The plasmid was digested with NruI and integrated at the leu1 locus in 
AP3788, a mid1-mEGFP::kanMX6 cdr2-TagRFP::natMX6 strain.
For strong overexpression, Cdr2-Cter, Cdr2-Cterbsc, Cdr2-CterFF*, 
and Kcc4-Cter were cloned between NdeI and NotI in pREP1-GST, a gift 
from P. Perez (Instituto de Biología Funcional y Genómica, Salamanca, 
Spain). For bacterial expression, Cdr2-Cter was cloned between BamHI 
and NotI sites in pGEX6p-1 (GE Healthcare).
Various serine to alanine mutants in Cdr2 phosphosites on the basic 
domain were produced by site-directed mutagenesis of pSM788, a pBlue-
script plasmid carrying Cdr2 ORF and 5UTR and 3UTR regions between 
NotI and SalI. Cdr2 fragments amplified from pSM788 or the mutant plas-
mids were cloned between BamHI and XhoI sites in pGEX-4T-1 or NotI and 
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Triton X-100 in PBS buffer at 4°C, and centrifuged 15 min at 4°C at 
10,000 g. Soluble extract was incubated with 200 µl glutathione–Sepharose 
beads at 50% slurry for 2 h at 4°C. Finally, beads were washed 3× with 
cold PBS and eluted in four steps in 100 µl elution buffer (15 mM reduced 
glutathione and 50 mM Tris-HCl, pH 8). Eluted proteins were incubated 
with lipid strips (Echelon, Inc.) following the manufacturer’s protocol. Lipid 
strips were probed with a rabbit affinity-purified anti-GST antibody (1:100; 
gift from J. Dumont).
Recombinant protein production and in vitro kinase assay
Expression of GST-Cdr2 fragments from pGEX-4T-1–derived plasmids 
was performed as described in the “Recombinant protein production and 
lipid-binding assay” section. MBP-TEV-Cdr2(518–620) and MBP-TEV-
Cdr2(518–620)S604-607-616-618-4A fragments were also induced in BL21 cells 
from pMAL-TEV–derived plasmid as described in the “Recombinant protein 
production and lipid-binding assay” section. In brief, cells were grown 
overnight in LB supplemented with 100 µg/ml ampicillin at 37°C. 250 ml 
of LB-ampicillin was inoculated with 6.25 ml of the saturated culture, grown 
3 h at 37°C. Protein expression was induced by the addition of 100 µM 
IPTG for 5 h at 18°C. Bacterial pellets were resuspended in 10 ml of cold 
resuspension buffer (50 mM Tris-Cl, pH 8, 1 mM EDTA, 100 mM KCl, and 
PMSF), sonicated 3× for 30 s (50% amplitude), incubated with 1% Triton 
X-100 at 4°C, and centrifuged 15 min at 4°C at 10,000 g. Soluble extract 
was incubated with 400 µl amylose resin (New England Biolabs, Inc.) for 
2 h at 4°C. Finally, beads were washed 3× with cold resuspension buffer 
and eluted in three steps in 100 µl elution buffer (50 mM Tris-Cl, pH 8, 
1 mM EDTA, 100 mM KCl, and 10 mM maltose).
For kinase assays, recombinant GST-Pom1 or GST-Pom1KD fusion pro-
teins were expressed in BL21 cells and purified with glutathione–Sepharose 
4B (GE Healthcare) columns according to the manufacturer’s protocol 
(Hachet et al., 2011). Kinase assays were performed in 30 mM Tris, 100 mM 
NaCl, 10 mM MgCl2, 1 mM EGTA, 10% glycerol, 1 mM DTT, 20 µM ATP, 
and 2 µCi [32P]ATP (PerkinElmer) in a 15-µl final volume reaction. After a 
30-min incubation at 30°C, the reaction was stopped by boiling in sample 
buffer and analyzed by SDS-PAGE. 32P incorporation was detected with a 
phosphorimager (Typhoon FLA 7000; GE Healthcare). Silver staining was 
performed according to the manufacturer’s protocol (Silver Stain Kit; Thermo 
Fisher Scientific) to check for equivalent amounts of substrates.
Online supplemental material
Fig. S1 reports additional properties of Cdr2 C-terminal domain. Fig. S2 
shows the localization of the Cdr2bsc*-FF* mutant and of Cdr2-Cter in 
mid1400–450 mutant. Fig. S3 analyses the role of Pom1, Mid1, and Cdr2 
kinase activity in Cdr2 node assembly. Fig. S4 defines how Pom1 phos-
phorylates the Cdr2 basic region. Fig. S5 analyses the dynamic exchange 
on the cortex of Cdr2 phosphoinhibitory or phosphomimetic mutants in the 
basic region. Tables S1 and S2 list strains and plasmids used in this study, 
respectively. Table S3 reports cell length at division in Cdr2 mutants in the 
C-terminal–anchoring domain. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.201311097/DC1.
We thank M. Riou and P. Paoletti for invaluable help to produce the Cdr2 KA-1 
3D model and A. Sansaloni for help with strain construction. We also thank J. 
Dumont, J. Moseley, and P. Perez for strains, plasmids, and reagents and 
Phong Tran for critical reading of the manuscript.
This work was supported by Ligue Nationale Contre le Cancer (Pro-
gramme Labellisation), Ligue Contre le Cancer Comité de Paris, and Mairie de 
Paris (Programme Emergence) to A. Paoletti as well as a European Research 
Council Starting Grant (260493) and a Swiss National Science Foundation 
research grant (31003A_138177) to S.G. Martin. A. Paoletti is a member of 
LabEx CelTisPhyBio, which is part of Idex PSL* (Initiative D’Excellence Paris 
Sciences et Lettres). S.A. Rincon received postdoctoral fellowships from Funda-
cion Ramon Areces and the Marie Curie FP7 program. M. Guzman-Vendrell 
received a PhD fellowship from Université Paris-Sud and Association pour la 
Recherche sur le Cancer.
The authors declare no competing financial interests.
Submitted: 25 November 2013
Accepted: 28 May 2014
References
Akamatsu, M., J. Berro, K.M. Pu, I.R. Tebbs, and T.D. Pollard. 2014. 
Cytokinetic nodes in fission yeast arise from two distinct types of nodes 
that merge during interphase. J. Cell Biol. 204:977–988. http://dx.doi 
.org/10.1083/jcb.201307174
gels. Excised gel slices were washed, and proteins were reduced with 
10 mM DTT before alkylation with 55 mM iodoacetamide. After washing 
and shrinking of the gel pieces with 100% acetonitrile, in-gel digestion was 
performed using trypsin (Sequencing Grade; Promega) overnight in 
25 mM ammonium bicarbonate at 30°C. The extracted peptides were ana-
lyzed by nano–liquid chromatography-MS/MS using an UltiMate 3000 
system (Dionex) coupled to a mass spectrometer (LTQ Orbitrap XL; Thermo 
Fisher Scientific). Samples were loaded on a C18 precolumn (300-µm 
inner diameter × 5 mm; Dionex) at 20 µl/min in 5% acetonitrile and 0.1% 
TFA. After 3 min of desalting, the precolumn was switched on line with the 
analytical C18 column (75-µm inner diameter × 50 cm; C18 PepMap; Di-
onex) equilibrated in solvent A (2% acetonitrile and 0.1% formic acid). 
Bound peptides were eluted using a 160-min linear gradient (from 0 to 
30% [vol/vol]) of solvent B (80% acetonitrile and 0.085% formic acid) at 
a 150-nl/min flow rate and an oven temperature of 40°C. Data-dependent 
acquisition was performed on the mass spectrometer (LTQ Orbitrap XL) in 
the positive ion mode. Survey MS scans were acquired in the LTQ Orbitrap 
XL on the 400–1,200 mass per charge range with the resolution set to a 
value of 100,000. Each scan was recalibrated in real time by coinjecting 
an internal standard from ambient air into the C-trap (lock mass option). 
The five most intense ions per survey scan were selected for collision- 
induced dissociation fragmentation, and the resulting fragments were ana-
lyzed in the linear trap (LTQ Orbitrap XL). Target ions already selected for 
MS/MS were dynamically excluded for 30 s. Data were acquired using 
the Xcalibur software (version 2.2; Thermo Fisher Scientific), and the result-
ing spectra were then analyzed via the Mascot and the Sequest software 
created with Proteome Discoverer (version 1.4; Thermo Fisher Scientific) 
using the Swiss-Prot Schizosaccharomyces pombe (fission yeast) database, 
containing 5,089 protein sequences. Carbamidomethylation of cysteines, 
oxidation of methionine, protein N-terminal acetylation, and phosphory-
lated serine, threonine, and tyrosine were set as variable modifications for 
all searches. Specificity of trypsin digestion was set, and two missed cleav-
age site were allowed. The mass tolerances in MS and MS/MS were set to 
5 ppm and 0.5 D, respectively. Phosphorylated peptides with nonphos-
phorylated counterparts were validated manually.
Cdr2–Cdr2 and Cdr2–Mid1 interaction experiments
Immunoprecipitations experiments shown in Figs. 4 B and 6 B were per-
formed as previously described (Almonacid et al., 2011). In brief, 200 ml 
of cells grown at 1.6 × 107 cells/ml at 30°C in YE5S was resuspended in 
300 µl NP-40 buffer (Celton-Morizur et al., 2004). Extracts were incubated 
with anti–mouse IgG magnetic beads (M-280 Dynal; Invitrogen), coupled 
to 6 µg anti-GFP mAB (Roche). Western blots were probed with anti-GFP 
mAb (1:500; Roche), antimyc mAb 9E10 (1:666; Roche), or anti-Mid1 
affinity-purified Ab (1:100; Celton-Morizur et al., 2004). Secondary anti-
bodies were coupled to peroxidase (Jackson ImmunoResearch Labora-
tories, Inc.). Signal quantification was performed with Image Lab 4.0.1 
(Bio-Rad Laboratories). Signals of coimmunoprecipitated proteins were nor-
malized relative to the amount of primarily immunoprecipitated protein.
For interactions between differentially tagged Cdr2-Cter shown in 
Figs. 2 C and 3 C, protein extracts were produced from 200 ml cdr2 cells 
carrying GST–Cdr2-Cter, GST–Cdr2-CterFF*, GST–Cdr2-Cterbsc, or GST–
Kcc4-Cter plasmids grown for 20 h in Edinburgh minimal medium without 
thiamine at 30°C to an OD of 0.8 at 600 nm to induce GST–Cdr2-Cter, 
GST–Cdr2-CterFF*, GST–Cdr2-Cterbsc, or GST–Kcc4-Cter overexpression. 
200 µl of extract was incubated for 2 h at 4°C with 7.5 µl of dry gluta-
thione–Sepharose beads. Separate protein extracts were produced from 
200 ml cdr2 cells expressing Cdr2-Cter–myc12, Cdr2-CterFF*–myc12, Cdr2-
Cterbsc–myc12, or Kcc4-Cter–myc12 from the leu1 locus grown at 30°C to 
OD of 0.8 at 600 nm in YE5S. Beads were washed five times with NP-40 
buffer. Pull-downs and supernatants were submitted to SDS-PAGE. Western 
blots were probed with a rabbit affinity-purified anti-GST antibody (1:100; 
gift from J. Dumont, Institut Jacques Monod, Paris, France), and the antimyc 
mAb 9E10 (1:666). Secondary antibodies were coupled to peroxidase.
Recombinant protein production and lipid-binding assay
Expression of GST–Cdr2-Cter or GST was induced in BL21 bacteria from 
the pGEX6p-1–derived plasmid described in Production of mutant and 
tagged strains. In brief, cells were grown overnight in LB (Luria–Bertani) 
medium supplemented with 100 µg/ml ampicillin at 37°C. 500 ml LB and 
100 µg/ml ampicillin were inoculated with 12.5 ml of the saturated culture, 
grown for 4 h at 30°C. Protein expression was induced by the addition 
of 1 mM IPTG and incubation for 1 h. Bacterial pellets were resus-
pended in 5 ml PBS, digested with 1 mg/ml lysozyme, treated with 1 µg/ml 
DNase I, sonicated twice for 1 min (50% amplitude), incubated with 1% 
 o
n
 July 7, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published June 30, 2014
JCB • VOLUME 206 • NUMBER 1 • 2014 76
Goyal, A., M. Takaine, V. Simanis, and K. Nakano. 2011. Dividing the spoils 
of growth and the cell cycle: The fission yeast as a model for the study 
of cytokinesis. Cytoskeleton (Hoboken). 68:69–88. http://dx.doi.org/10 
.1002/cm.20500
Green, R.A., E. Paluch, and K. Oegema. 2012. Cytokinesis in animal cells. 
Annu. Rev. Cell Dev. Biol. 28:29–58. http://dx.doi.org/10.1146/annurev­ 
cellbio­101011­155718
Guzman­Vendrell, M., S. Baldissard, M. Almonacid, A. Mayeux, A. Paoletti, 
and J.B. Moseley. 2013. Blt1 and Mid1 provide overlapping membrane 
anchors to position the division plane in fission yeast. Mol. Cell. Biol. 
33:418–428. http://dx.doi.org/10.1128/MCB.01286­12
Hachet, O., and V. Simanis. 2008. Mid1p/anillin and the septation initiation net­
work orchestrate contractile ring assembly for cytokinesis. Genes Dev. 
22:3205–3216. http://dx.doi.org/10.1101/gad.1697208
Hachet, O., M. Berthelot­Grosjean, K. Kokkoris, V. Vincenzetti, J. Moosbrugger, 
and S.G. Martin. 2011. A phosphorylation cycle shapes gradients of the 
DYRK family kinase Pom1 at the plasma membrane. Cell. 145:1116–
1128. http://dx.doi.org/10.1016/j.cell.2011.05.014
Hachet, O., F.O. Bendezú, and S.G. Martin. 2012. Fission yeast: in shape to 
divide. Curr. Opin. Cell Biol. 24:858–864. http://dx.doi.org/10.1016/ 
j.ceb.2012.10.001
Hentges, P., B. Van Driessche, L. Tafforeau, J. Vandenhaute, and A.M. Carr. 
2005. Three novel antibiotic marker cassettes for gene disruption and 
marker switching in Schizosaccharomyces pombe. Yeast. 22:1013–1019. 
http://dx.doi.org/10.1002/yea.1291
Huang, Y., H. Yan, and M.K. Balasubramanian. 2008. Assembly of normal acto­
myosin rings in the absence of Mid1p and cortical nodes in fission yeast. 
J. Cell Biol. 183:979–988. http://dx.doi.org/10.1083/jcb.200806151
Iacovoni, J.S., P. Russell, and F. Gaits. 1999. A new inducible protein expres­
sion system in fission yeast based on the glucose­repressed inv1 promoter. 
Gene. 232:53–58. http://dx.doi.org/10.1016/S0378­1119(99)00116­X
Jourdain, I., E.A. Brzezińska, and T. Toda. 2013. Fission yeast Nod1 is a com­
ponent of cortical nodes involved in cell size control and division site 
placement. PLoS ONE. 8:e54142. http://dx.doi.org/10.1371/journal 
.pone.0054142
Kanoh, J., and P. Russell. 1998. The protein kinase Cdr2, related to Nim1/Cdr1 
mitotic inducer, regulates the onset of mitosis in fission yeast. Mol. Biol. 
Cell. 9:3321–3334. http://dx.doi.org/10.1091/mbc.9.12.3321
Keeney, J.B., and J.D. Boeke. 1994. Efficient targeted integration at leu1­32 and 
ura4­294 in Schizosaccharomyces pombe. Genetics. 136:849–856.
Laporte, D., R. Zhao, and J.Q. Wu. 2010. Mechanisms of contractile­ring assem­
bly in fission yeast and beyond. Semin. Cell Dev. Biol. 21:892–898. http://
dx.doi.org/10.1016/j.semcdb.2010.08.004
Laporte, D., V.C. Coffman, I.J. Lee, and J.Q. Wu. 2011. Assembly and archi­
tecture of precursor nodes during fission yeast cytokinesis. J. Cell Biol. 
192:1005–1021. http://dx.doi.org/10.1083/jcb.201008171
Laporte, D., N. Ojkic, D. Vavylonis, and J.Q. Wu. 2012. ­Actinin and fim­
brin cooperate with myosin II to organize actomyosin bundles during 
contractile­ring assembly. Mol. Biol. Cell. 23:3094–3110. http://dx.doi 
.org/10.1091/mbc.E12­02­0123
Lee, I.J., V.C. Coffman, and J.Q. Wu. 2012. Contractile­ring assembly in fission 
yeast cytokinesis: Recent advances and new perspectives. Cytoskeleton 
(Hoboken). 69:751–763. http://dx.doi.org/10.1002/cm.21052
Lemmon, M.A. 2008. Membrane recognition by phospholipid­binding domains. 
Nat. Rev. Mol. Cell Biol. 9:99–111. http://dx.doi.org/10.1038/nrm2328
Lewellyn, L., J. Dumont, A. Desai, and K. Oegema. 2010. Analyzing the effects 
of delaying aster separation on furrow formation during cytokinesis in the 
Caenorhabditis elegans embryo. Mol. Biol. Cell. 21:50–62. http://dx.doi 
.org/10.1091/mbc.E09­01­0089
Martin, S.G. 2009. Microtubule­dependent cell morphogenesis in the fission yeast. 
Trends Cell Biol. 19:447–454. http://dx.doi.org/10.1016/j.tcb.2009.06.003
Martin, S.G., and M. Berthelot­Grosjean. 2009. Polar gradients of the DYRK­
family kinase Pom1 couple cell length with the cell cycle. Nature. 
459:852–856. http://dx.doi.org/10.1038/nature08054
Moravcevic, K., J.M. Mendrola, K.R. Schmitz, Y.H. Wang, D. Slochower, P.A. 
Janmey, and M.A. Lemmon. 2010. Kinase associated­1 domains drive 
MARK/PAR1 kinases to membrane targets by binding acidic phospho­
lipids. Cell. 143:966–977. http://dx.doi.org/10.1016/j.cell.2010.11.028
Moreno, S., A. Klar, and P. Nurse. 1991. Molecular genetic analysis of fission 
yeast Schizosaccharomyces pombe. Methods Enzymol. 194:795–823. 
http://dx.doi.org/10.1016/0076­6879(91)94059­L
Morrell, J.L., C.B. Nichols, and K.L. Gould. 2004. The GIN4 family ki­
nase, Cdr2p, acts independently of septins in fission yeast. J. Cell Sci. 
117:5293–5302. http://dx.doi.org/10.1242/jcs.01409
Moseley, J.B., A. Mayeux, A. Paoletti, and P. Nurse. 2009. A spatial gradient 
coordinates cell size and mitotic entry in fission yeast. Nature. 459:857–
860. http://dx.doi.org/10.1038/nature08074
Almonacid, M., and A. Paoletti. 2010. Mechanisms controlling division­plane 
positioning. Semin. Cell Dev. Biol. 21:874–880. http://dx.doi.org/10 
.1016/j.semcdb.2010.08.006
Almonacid, M., J.B. Moseley, J. Janvore, A. Mayeux, V. Fraisier, P. Nurse, 
and A. Paoletti. 2009. Spatial control of cytokinesis by Cdr2 kinase 
and Mid1/anillin nuclear export. Curr. Biol. 19:961–966. http://dx.doi 
.org/10.1016/j.cub.2009.04.024
Almonacid, M., S. Celton­Morizur, J.L. Jakubowski, F. Dingli, D. Loew, A. 
Mayeux, J.S. Chen, K.L. Gould, D.M. Clifford, and A. Paoletti. 2011. 
Temporal control of contractile ring assembly by Plo1 regulation of myo­
sin II recruitment by Mid1/anillin. Curr. Biol. 21:473–479. http://dx.doi 
.org/10.1016/j.cub.2011.02.003
Alvarez­Tabarés, I., A. Grallert, J.M. Ortiz, and I.M. Hagan. 2007. Schizo-
saccharomyces pombe protein phosphatase 1 in mitosis, endocytosis and 
a partnership with Wsh3/Tea4 to control polarised growth. J. Cell Sci. 
120:3589–3601. http://dx.doi.org/10.1242/jcs.007567
Aranda, S., A. Laguna, and S. de la Luna. 2011. DYRK family of pro­
tein kinases: evolutionary relationships, biochemical properties, and 
functional roles. FASEB J. 25:449–462. http://dx.doi.org/10.1096/ 
fj.10­165837
Bähler, J., and J.R. Pringle. 1998. Pom1p, a fission yeast protein kinase that pro­
vides positional information for both polarized growth and cytokinesis. 
Genes Dev. 12:1356–1370. http://dx.doi.org/10.1101/gad.12.9.1356
Bähler, J., J.Q. Wu, M.S. Longtine, N.G. Shah, A. McKenzie III, A.B. 
Steever, A. Wach, P. Philippsen, and J.R. Pringle. 1998. Heterolo­
gous modules for efficient and versatile PCR­based gene targeting 
in Schizosaccharomyces pombe. Yeast. 14:943–951. http://dx.doi 
.org/10.1002/(SICI)1097­0061(199807)14:10<943::AID­YEA292> 
3.0.CO;2­Y
Balasubramanian, M.K., R. Srinivasan, Y. Huang, and K.H. Ng. 2012. 
Comparing contractile apparatus­driven cytokinesis mechanisms across 
kingdoms. Cytoskeleton (Hoboken). 69:942–956. http://dx.doi.org/10 
.1002/cm.21082
Bathe, M., and F. Chang. 2010. Cytokinesis and the contractile ring in fission 
yeast: towards a systems­level understanding. Trends Microbiol. 18:38–
45. http://dx.doi.org/10.1016/j.tim.2009.10.002
Bhatia, P., O. Hachet, M. Hersch, S.A. Rincon, M. Berthelot­Grosjean, S. 
Dalessi, L. Basterra, S. Bergmann, A. Paoletti, and S.G. Martin. 2014. 
Distinct levels in Pom1 gradients limit Cdr2 activity and localization 
to time and position division. Cell Cycle. 13:538–552. http://dx.doi 
.org/10.4161/cc.27411
Bohnert, K.A., A.P. Grzegorzewska, A.H. Willet, C.W. Vander Kooi, D.R. 
Kovar, and K.L. Gould. 2013. SIN­dependent phosphoinhibition of 
formin multimerization controls fission yeast cytokinesis. Genes Dev. 
27:2164–2177. http://dx.doi.org/10.1101/gad.224154.113
Breeding, C.S., J. Hudson, M.K. Balasubramanian, S.M. Hemmingsen, P.G. 
Young, and K.L. Gould. 1998. The cdr2(+) gene encodes a regulator of 
G2/M progression and cytokinesis in Schizosaccharomyces pombe. Mol. 
Biol. Cell. 9:3399–3415. http://dx.doi.org/10.1091/mbc.9.12.3399
Campbell, L.E., and C.G. Proud. 2002. Differing substrate specificities of mem­
bers of the DYRK family of arginine­directed protein kinases. FEBS Lett. 
510:31–36. http://dx.doi.org/10.1016/S0014­5793(01)03221­5
Celton­Morizur, S., N. Bordes, V. Fraisier, P.T. Tran, and A. Paoletti. 2004. C­
terminal anchoring of mid1p to membranes stabilizes cytokinetic ring po­
sition in early mitosis in fission yeast. Mol. Cell. Biol. 24:10621–10635. 
http://dx.doi.org/10.1128/MCB.24.24.10621­10635.2004
Celton­Morizur, S., V. Racine, J.B. Sibarita, and A. Paoletti. 2006. Pom1 
kinase links division plane position to cell polarity by regulating 
Mid1p cortical distribution. J. Cell Sci. 119:4710–4718. http://dx.doi 
.org/10.1242/jcs.03261
Chang, F., A. Woollard, and P. Nurse. 1996. Isolation and characterization of 
fission yeast mutants defective in the assembly and placement of the con­
tractile actin ring. J. Cell Sci. 109:131–142.
Coleman, T.R., Z. Tang, and W.G. Dunphy. 1993. Negative regulation of the 
wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer. 
Cell. 72:919–929. http://dx.doi.org/10.1016/0092­8674(93)90580­J
Daga, R.R., and F. Chang. 2005. Dynamic positioning of the fission yeast cell 
division plane. Proc. Natl. Acad. Sci. USA. 102:8228–8232. http://dx.doi 
.org/10.1073/pnas.0409021102
Deng, L., S. Baldissard, A.N. Kettenbach, S.A. Gerber, and J.B. Moseley. 
2014. Dueling kinases regulate cell size at division through the SAD 
kinase Cdr2. Curr. Biol. 24:428–433. http://dx.doi.org/10.1016/j.cub 
.2014.01.009
Fededa, J.P., and D.W. Gerlich. 2012. Molecular control of animal cell cytokine­
sis. Nat. Cell Biol. 14:440–447. http://dx.doi.org/10.1038/ncb2482
Fuller, B.G. 2010. Self­organization of intracellular gradients during mitosis. Cell 
Div. 5:5. http://dx.doi.org/10.1186/1747­1028­5­5
 o
n
 July 7, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published June 30, 2014
77Pom1 control of Cdr2 node distribution • Rincon et al.
Ojkic, N., J.Q. Wu, and D. Vavylonis. 2011. Model of myosin node aggregation 
into a contractile ring: the effect of local alignment. J. Phys. Condens. 
Matter. 23:374103. http://dx.doi.org/10.1088/0953­8984/23/37/374103
Oliferenko, S., T.G. Chew, and M.K. Balasubramanian. 2009. Positioning cyto­
kinesis. Genes Dev. 23:660–674. http://dx.doi.org/10.1101/gad.1772009
Padmanabhan, A., K. Bakka, M. Sevugan, N.I. Naqvi, V. D’souza, X. Tang, M. 
Mishra, and M.K. Balasubramanian. 2011. IQGAP­related Rng2p orga­
nizes cortical nodes and ensures position of cell division in fission yeast. 
Curr. Biol. 21:467–472. http://dx.doi.org/10.1016/j.cub.2011.01.059
Padte, N.N., S.G. Martin, M. Howard, and F. Chang. 2006. The cell­end factor 
pom1p inhibits mid1p in specification of the cell division plane in fission 
yeast. Curr. Biol. 16:2480–2487. http://dx.doi.org/10.1016/j.cub.2006 
.11.024
Parker, L.L., S.A. Walter, P.G. Young, and H. Piwnica­Worms. 1993. Phos­
phorylation and inactivation of the mitotic inhibitor Wee1 by the nim1/
cdr1 kinase. Nature. 363:736–738. http://dx.doi.org/10.1038/363736a0
Pollard, T.D., and J.Q. Wu. 2010. Understanding cytokinesis: lessons from fis­
sion yeast. Nat. Rev. Mol. Cell Biol. 11:149–155. http://dx.doi.org/10 
.1038/nrm2834
Rincon, S.A., and A. Paoletti. 2012. Mid1/anillin and the spatial regulation of 
cytokinesis in fission yeast. Cytoskeleton (Hoboken). 69:764–777. http://
dx.doi.org/10.1002/cm.21056
Roberts­Galbraith, R.H., M.D. Ohi, B.A. Ballif, J.S. Chen, I. McLeod, 
W.H. McDonald, S.P. Gygi, J.R. Yates III, and K.L. Gould. 2010. 
Dephosphorylation of F­BAR protein Cdc15 modulates its conformation 
and stimulates its scaffolding activity at the cell division site. Mol. Cell. 
39:86–99. http://dx.doi.org/10.1016/j.molcel.2010.06.012
Russell, P., and P. Nurse. 1987a. The mitotic inducer nim1+ functions in a regula­
tory network of protein kinase homologs controlling the initiation of mitosis. 
Cell. 49:569–576. http://dx.doi.org/10.1016/0092­8674(87)90459­4
Russell, P., and P. Nurse. 1987b. Negative regulation of mitosis by wee1+, a gene 
encoding a protein kinase homolog. Cell. 49:559–567. http://dx.doi.org/10 
.1016/0092­8674(87)90458­2
Saha, S., and T.D. Pollard. 2012. Characterization of structural and functional 
domains of the anillin­related protein Mid1p that contribute to cyto­
kinesis in fission yeast. Mol. Biol. Cell. 23:3993–4007. http://dx.doi 
.org/10.1091/mbc.E12­07­0536
Šali, A., and T.L. Blundell. 1993. Comparative protein modelling by satisfac­
tion of spatial restraints. J. Mol. Biol. 234:779–815. http://dx.doi.org/ 
10.1006/jmbi.1993.1626
Saunders, T.E., K.Z. Pan, A. Angel, Y. Guan, J.V. Shah, M. Howard, and F. 
Chang. 2012. Noise reduction in the intracellular pom1p gradient by a 
dynamic clustering mechanism. Dev. Cell. 22:558–572. http://dx.doi.org/ 
10.1016/j.devcel.2012.01.001
Sohrmann, M., C. Fankhauser, C. Brodbeck, and V. Simanis. 1996. The dmf1/
mid1 gene is essential for correct positioning of the division septum 
in fission yeast. Genes Dev. 10:2707–2719. http://dx.doi.org/10.1101/ 
gad.10.21.2707
Vavylonis, D., J.Q. Wu, S. Hao, B. O’Shaughnessy, and T.D. Pollard. 2008. 
Assembly mechanism of the contractile ring for cytokinesis by fission 
yeast. Science. 319:97–100. http://dx.doi.org/10.1126/science.1151086
Wachtler, V., S. Rajagopalan, and M.K. Balasubramanian. 2003. Sterol­rich 
plasma membrane domains in the fission yeast Schizosaccharomyces 
pombe. J. Cell Sci. 116:867–874. http://dx.doi.org/10.1242/jcs.00299
White, E.A., and M. Glotzer. 2012. Centralspindlin: at the heart of cytokine­
sis. Cytoskeleton (Hoboken). 69:882–892. http://dx.doi.org/10.1002/cm 
.21065
Wood, E., and P. Nurse. 2013. Pom1 and cell size homeostasis in fission yeast. 
Cell Cycle. 12:3228–3236. http://dx.doi.org/10.4161/cc.26462
Wu, J.Q., and T.D. Pollard. 2005. Counting cytokinesis proteins glob­
ally and locally in fission yeast. Science. 310:310–314. http://dx.doi 
.org/10.1126/science.1113230
Wu, J.Q., J.R. Kuhn, D.R. Kovar, and T.D. Pollard. 2003. Spatial and tempo­
ral pathway for assembly and constriction of the contractile ring in fis­
sion yeast cytokinesis. Dev. Cell. 5:723–734. http://dx.doi.org/10.1016/ 
S1534­5807(03)00324­1
Wu, L., and P. Russell. 1993. Nim1 kinase promotes mitosis by inactivating 
Wee1 tyrosine kinase. Nature. 363:738–741. http://dx.doi.org/10.1038/ 
363738a0
Ye, Y., I.J. Lee, K.W. Runge, and J.Q. Wu. 2012. Roles of putative Rho­GEF 
Gef2 in division­site positioning and contractile­ring function in fis­
sion yeast cytokinesis. Mol. Biol. Cell. 23:1181–1195. http://dx.doi 
.org/10.1091/mbc.E11­09­0800
Zhu, Y.H., Y. Ye, Z. Wu, and J.Q. Wu. 2013. Cooperation between Rho­GEF 
Gef2 and its binding partner Nod1 in the regulation of fission yeast cy­
tokinesis. Mol. Biol. Cell. 24:3187–3204. http://dx.doi.org/10.1091/mbc 
.E13­06­0301
 o
n
 July 7, 2014
jcb.rupress.org
D
ow
nloaded from
 
Published June 30, 2014
Pom1 control of Cdr2 node distribution • Rincon et al.
T
H
E
 J
O
U
R
N
A
L
 O
F
 C
E
L
L
 B
IO
L
O
G
Y
S1
JCBSupplemental material
Rincon et al., http://www.jcb.org/cgi/content/full/jcb.201311097/DC1
Figure S1.  Properties of Cdr2 C-terminal domain. (A) Medial plane epifluorescence images of mEGFP-tagged Cdr2 mutated in the C-terminal basic region 
(Cdr2bsc*), carrying a deletion of the basic region (Cdr2bsc; deletion of residues 591–620) or mutated in the predicted helices of the KA-1 domain 
(Cdr2hlx1*, Cdr2hlx2*, and Cdr2hlx3*). Bar, 5 µm. (B) Kcc4 KA-1 structure 3OST highlighting surface-exposed basic residues involved in lipid binding accord-
ing to Moravcevic et al. (2010) and equivalent positions in the Cdr2 KA-1 model with nonconserved residues, except R682 that corresponds to K978 on 
Kcc4 KA-1. Note that the structure and model are rotated by 180° compared with those shown in Figs. 1 B or 2 D. (C) Protein–lipid overlay assay with 
GST (negative control; left) and GST–Cdr2-Cter (right) purified from Escherichia coli. Signal was enhanced using a  of 1.3. Dim signals are likely caused 
by the very low amount of soluble GST–Cdr2-Cter produced in E. coli. PI, phosphatidylinositol; TG, triglyceride; PA, phosphatidic acid; PS, phosphatidyl-
serine; PE, phosphatidylethanolamine; PC, phosphatidylcholine; PG, phosphatidylglycerol.
JCB S2 
Figure S2.  Localization of the Cdr2bsc*-FF* mutant and of Cdr2-Cter in the mid1400–450 mutant. (A) Medial plane epifluorescence images of Cdr2-mEGFP, 
Cdr2FF*-mEGFP, Cdr2bsc*-mEGFP, or Cdr2bsc*-FF*-mEGFP in wild-type cells. (B) Medial plane epifluorescence images of GFP–Cdr2-Cter in wild type (wt; top) 
and the mid1400–450 mutant (bottom). Bars, 5 µm.
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Figure S3.  Role of Pom1, Mid1, and Cdr2 kinase activity in Cdr2 node assembly. (A) Mean FRAP of Cdr2-mEGFP on the medial cortex or at cell tips in 
pom1 cells. Error bars show SDs. Cdr2 t1/2: medial cortex t1/2 = 3 min; tip t1/2 < 2 min. B, bleach. (B, top) Medial plane confocal images of Mid1-
mEGFP and Cdr2-TagRFP in a pom1 cell. Bar, 4 µm. (bottom) Mid1-mEGFP and Cdr2-TagRFP intensity along the cortex in the same cell. The line scan 
starts from top medial cortex, goes around the left cell tip, and continues until the bottom medial cortex. (bottom right) Mean percentage of Cdr2-TagRFP 
nodes containing Mid1-mEGFP in individual cells. Error bars show SDs (n = 25 cells). (C) Medial plane epifluorescence images of Cdr2-mEGFP and 
Cdr2FF*-mEGFP in wild-type (wt) cells or cells expressing Pom1-chimera or carrying a Cdr2 kinase-dead mutation (E177A). (D) Medial plane confocal im-
ages of Cdr2-mEGFP or Cdr2KD-mEGFP in wild-type cells or the mid1400–450 mutant. (E) Mean FRAP of Cdr2-mEGFP or Cdr2KD-mEGFP on the medial cortex 
in wild-type cells or mid1400–450. Error bars show SDs. Cdr2 t1/2: wild type t1/2 = 3 min; mid1400–450 t1/2 < 2 min; Cdr2KD t1/2 < 2 min; mid1400–450 
Cdr2KD t1/2 = 2 min. Bar, 5 µm.
JCB S4 
Figure S4.  Pom1 phosphorylates Cdr2 basic region. (A) MS2 spectra of Cdr2 phosphorylated peptides within the Cdr2 basic motif. The fragmentation 
spectra are derived from trypsin-digested Cdr2-GFP purified with anti-GFP mAb. The phosphopeptide sequences and observed ions are indicated on top 
of the spectra. Singly and doubly charged b and y ions as well as ion corresponding to neutral losses of water (circles), NH3 (asterisks), and H3PO4 (98 D) 
groups are shown. M, parent ion mass. (B and C) In vitro kinase assay of GST-Pom1 or GST-Pom1KD on GST-Cdr2(518–620) with the indicated mutations. 
(top) Phosphorimager detection of 32P incorporation. (bottom) Silver-stained gel. The second and third lanes of the silver-stained gel show the same input 
sample. A control using GST-Pom1KD shows no 32P incorporation. Molecular masses are indicated. wt, wild type. Black lines indicate that intervening lanes 
have been spliced out.
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Figure S5.  Dynamic exchange on the cortex of Cdr2 phosphoinhibitory or phosphomimetic mutations in the basic region. (A) Localization of mEGFP-
tagged Cdr2, Cdr2bsc-3D, and Cdr2bsc-3A at the tips of wild-type cells. Arrows show cell tip localization. Inverted black and white pictures are depicted. 
Bar, 5 µm. (right) Percentage of cells with Cdr2, Cdr2bsc-3D, and Cdr2bsc-3A detected at cell tips. n > 150 cells. (B) Mean FRAP of mEGFP-tagged Cdr2, 
Cdr2bsc-3R, and Cdr2bsc-3D on the medial cortex. Error bars shows SDs. Cdr2 t1/2 > 2 min; Cdr2bsc-3R t1/2 > 2 min; Cdr2bsc-3D t1/2 < 1 min. B, bleach.
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Table S1. List of strains used in this study
Strain number Genotype Source
Fig. 1
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP3568 h cdr2RKRKR*-mEGFP:kanMX6 leu1-32 This work
AP3112 h cdr2bsc*-mEGFP:kanMX6 leu1-32 This work
AP3418 h cdr2RR*-mEGFP:kanMX6 leu1-32 This work
AP3548 h cdr2RR*-RKRKR*-mEGFP:kanMX6 leu1-32 This work
AP3546 h cdr2bsc*-RKRKR-mEGFP:kanMX6 leu1-32 This work
AP3526 h cdr2bsc-mEGFP:kanMX6 leu1-32 This work
Fig. 2
AP3081 h GFP–cdr2-Cter:kanMX6 leu1-32 ura4-D18 ade6-M210 This work
AP4764 h GFP–kcc4-Cter:kanMX6 leu1-32 This work
AP3986 h cdr2::natMX6 leu1+:Pcdr2-cdr2-Cter–myc12 This work
AP3988 h cdr2::natMX6 pREP1-GST–cdr2-Cter This work
AP4812 h kcc4-Cter–myc12:kanMX6 cdr2::natMX6 leu1-32 This work
AP4813 h cdr2::natMX6 pREP1-GST–kcc4-Cter leu1-32 This work
AP2804 h cdr2::natMX6 leu1-32 Laboratory stock
Fig. 3
AP3081 h GFP–cdr2-Cter:kanMX6 leu1-32 ura4-D18 ade6-M210 This work
AP3555 h GFP–cdr2-CterFF*:kanMX6 leu1-32 This work
AP3503 h GFP–cdr2-Cterbsc:kanMX6 leu1-32 This work
AP3986 h cdr2::natMX6 leu1+:Pcdr2-cdr2-Cter–myc12 This work
AP3987 h cdr2::natMX6 leu1+:Pcdr2-cdr2-CterFF*–myc12 This work
AP3988 h cdr2::natMX6 pREP1-GST–cdr2-Cter This work
AP3989 h cdr2::natMX6 pREP1-GST–cdr2-CterFF* This work
AP4744 h cdr2::natMX6 leu1+:Pcdr2-cdr2-Cterbsc–myc12 This work
AP4814 h cdr2::natMX6 pREP1-GST-Cterbsc leu1-32 This work
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP3428 h cdr2FF*-mEGFP:kanMX6 leu1-32 ura4-D18 ade6 This work
Fig. 4
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP3724 h cdr2-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 This work
AP3736 h cdr2N-kcc4C–GFP:kanMX6 leu1-32 This work
AP3959 h cdr2N-kcc4C–GFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 ade6 This work
AP3428 h cdr2FF*-mEGFP:kanMX6 leu1-32 ura4-D18 ade6 This work
AP3976 h+ cdr2FF*-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 ura4-D18 ade6 This work
AP4227 h+ leu1+:Pcdr2-cdr2-myc12 ura4-D18 ade6 This work
AP3533 h+ cdr2-mEGFP:kanMX6 leu1+:Pcdr2-cdr2-myc12 ura4-D18 ade6 This work
AP4232 h+ ura4+:cdr2N-kcc4C–myc12 This work
AP3956 h cdr2N-kcc4C–GFP:kanMX6 ura4+:cdr2N-kcc4C–myc12 leu1-32 This work
Fig. 5
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP3227 h+ cdr2-mEGFP:kanMX6 leu1+:Pmid1-pom1-chimera–mCherry This work
AP2876 h+ cdr2-mEGFP:kanMX6 pom1::natMX6 This work
Fig. 6
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP3227 h+ cdr2-mEGFP:kanMX6 leu1+:Pmid1-pom1-chimera–mCherry This work
AP3344 h cdr2KD-mEGFP:kanMX6 leu1-32 Laboratory stock
AP3736 h cdr2N-kcc4C–GFP:kanMX6 leu1-32 This work
AP4241 h cdr2N-kcc4C–GFP:kanMX6 leu1+:Pmid1-pom1-chimera–mCherry This work
AP3952 h cdr2NKD-kcc4C-GFP:kanMX6 leu1-32 This work
AP3788 h+ mid1-mEGFP:kanMX6 cdr2-TagRFP:natMX6 leu1-32 ura4-D18 This work
AP4218 h+ mid1-mEGFP:kanMX6 cdr2-TagRFP:natMX6 leu1+:Pmid1-pom1-chimera–HA3 ura4-D18 This work
AP4052 h mid1-mEGFP:kanMX6 cdr2KD-TagRFP:natMX6 leu1-32 ura4-D18 This work
Fig. 7
AP3081 h GFP–cdr2-Cter:kanMX6 leu1-32 ura4-D18 ade6-M210 This work
AP3062 h GFP–cdr2-Cter:kanMX6 pom1::natMX6 leu1-32 ura4-D18 ade6 This work
AP3055 h+ GFP–cdr2-Cter:kanMX6 leu1+:Pmid1-pom1-chimera–mCherry This work
AP3503 h GFP–cdr2-Cterbsc:kanMX6 leu1-32 This work
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Table S1. List of strains used in this study (Continued)
Strain number Genotype Source
AP4417 h GFP–cdr2-Cterbsc-3D:kanMX6 leu1-32 This work
AP4749 h GFP–cdr2-Cterbsc-3A:kanMX6 leu1-32 This work
Fig. 8
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP4462 h cdr2bsc-3D-mEGFP:kanMX6 leu1-32 This work
AP4740 h cdr2bsc-3A-mEGFP:kanMX6 leu1-32 This work
AP3724 h cdr2-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 This work
AP4442 h cdr2bsc-3D-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 This work
AP4754 h cdr2bsc-3A-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 ade6 This work
AP3344 h cdr2KD-mEGFP:kanMX6 leu1-32 Laboratory stock
AP4500 h cdr2KD bsc-3D-mEGFP:kanMX6 leu1-32 This work
AP4746 h cdr2KD bsc-3A-mEGFP:kanMX6 leu1-32 This work
AP4537 h cdr2-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1nsm ade6 This work
AP4756 h cdr2bsc-3A-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1nsm This work
AP2876 h+ cdr2-mEGFP:kanMX6 pom1::natMX6 This work
Fig. S1
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP3112 h cdr2bsc*-mEGFP:kanMX6 leu1-32 This work
AP3526 h cdr2bsc-mEGFP:kanMX6 leu1-32 This work
AP3136 h cdr2::natMX6 leu1+:Pcdr2-cdr2hlx1*-GFP This work
AP3140 h cdr2::natMX6 leu1+:Pcdr2-cdr2hlx2*-GFP This work
AP3142 h cdr2::natMX6 leu1+:Pcdr2-cdr2hlx3*-GFP This work
Fig. S2
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP3428 h cdr2FF*-mEGFP:kanMX6 leu1-32 ura4-D18 ade6 This work
AP3112 h cdr2bsc*-mEGFP:kanMX6 leu1-32 This work
AP3774 h cdr2bsc*FF*-mEGFP:kanMX6 leu1-32 This work
AP3081 h GFP–cdr2-Cter:kanMX6 leu1-32 ura4-D18 ade6-M210 This work
AP4230 h GFP–cdr2-Cter:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 This work
Fig. S3
AP2876 h+ cdr2-mEGFP:kanMX6 pom1::natMX6 This work
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP4766 h+ mid1-mEGFP:kanMX6 cdr2-TagRFP:natMX6 leu1-32 ura4-D18 pom1::ura4+ This work
AP3788 h+ mid1-mEGFP:kanMX6 cdr2-TagRFP:natMX6 leu1-32 ura4-D18 This work
AP3227 h+ cdr2-mEGFP:kanMX6 leu1+:Pmid1-pom1-chimera–mCherry This work
AP3344 h cdr2KD-mEGFP:kanMX6 leu1-32 Laboratory stock
AP3428 h cdr2FF*-mEGFP:kanMX6 leu1-32 ura4-D18 ade6 This work
AP3369 h+ cdr2FF*-mEGFP:kanMX6 leu1+:Pmid1-pom1-chimera–mCherry ura4-D18 ade6 This work
AP3768 h cdr2KD-FF*-mEGFP:kanMX6 leu1-32 This work
AP3724 h cdr2-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 This work
AP4004 h cdr2KD-mEGFP:kanMX6 mid1::ura4+ leu1+:Pmid1-mid1400–450 ura4-D18 ade6 This work
Fig. S5
AP3087 h cdr2-mEGFP:kanMX6 leu1-32 This work
AP4462 h cdr2bsc-3D-mEGFP:kanMX6 leu1-32 This work
AP4746 h cdr2KD bsc-3A-mEGFP:kanMX6 leu1-32 This work
AP4462 h cdr2bsc-3R-mEGFP:kanMX6 leu1-32 This work
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Table S2. List of plasmids used in this study
Systematic name Developed name Details of expressed construct
Fig. 1
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pSR105 pFA6a-kanMX6-Pcdr2-cdr2RKRKR*-mEGFP cdr2R682Q K684N R685Q K692N R695Q-mEGFP
pSR38 pFA6a-kanMX6-Pcdr2-cdr2bsc*-mEGFP cdr2K598N H599Q R600Q R601Q R602Q K612N K613N K614N-mEGFP
pSR85 pFA6a-kanMX6-Pcdr2-cdr2RR*-mEGFP cdr2R624Q R628Q-mEGFP
pSR122 pFA6a-kanMX6-Pcdr2-cdr2RR*-RKRKR*-mEGFP cdr2R624Q R628Q R682Q K684N R685Q K692N R695Q-mEGFP
pSR121 pFA6a-kanMX6-Pcdr2-cdr2bsc*-RKRKR*-mEGFP cdr2K598N H599Q R600Q R601Q R602Q K612N K613N K614N R682Q K684N R685Q K692N R695Q-mEGFP
pSR106 pFA6a-kanMX6-Pcdr2-cdr2bsc-mEGFP cdr2591–619-mEGFP
Fig. 2
pSR25 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cter GFP-cdr2(591–747)
pSR273 pFA6a-kanMX6-Pcdr2-GFP–kcc4-Cter GFP-kcc4(893–1,037)
pSR160 pJK148-Pcdr2-cdr2-Cter–myc12, leu1+ cdr2(591–747)-myc12
pSR152 pREP1-GST–cdr2-Cter GST-cdr2(591–747)
pSR288 pJK148-Pcdr2-kcc4-Cter–myc12, leu1+ kcc4(893–1,037)-myc12
pSR289 pREP1-GST–kcc4-Cter GST-kcc4(893–1,037)
Fig. 3
pSR25 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cter GFP-cdr2(591–747)
pSR111 pFA6a-kanMX6-Pcdr2-GFP–cdr2-CterFF* GFP-cdr2(591–747)F704D F705D
pSR102 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cterbsc GFP-cdr2(620–747)
pSR160 pJK148-Pcdr2-cdr2-Cter–myc12, leu1+ cdr2(591–747)-myc12
pSR161 pJK148-Pcdr2-cdr2-CterFF*–myc12, leu1+ cdr2(591–747)F704D F705D-myc12
pSR276 pJK148-Pcdr2-cdr2-Cterbsc–myc12, leu1+ cdr2(620–747)-myc12
pSR152 pREP1-GST–cdr2-Cter GST-cdr2(591–747)
pSR153 pREP1-GST–cdr2-CterFF* GST-cdr2(591–747)F704D F705D
pSR277 pREP1-GST–cdr2-Cterbsc GST-cdr2(591–619)
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pSR84 pFA6a-kanMX6-Pcdr2-cdr2FF*-mEGFP cdr2F704D F705D-mEGFP
Fig. 4
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pSR135 pFA6a-kanMX6-Pcdr2-cdr2N-kcc4C–GFP cdr2(1–590)-kcc4(917–1,037)–GFP
pSR84 pFA6a-kanMX6-Pcdr2-cdr2FF*-mEGFP cdr2F704D F705D-mEGFP
pSR98 pJK148-Pcdr2-cdr2-myc12, leu1+ cdr2-myc12
pSR163 pJK210-Pcdr2-cdr2N-kcc4C–myc12, ura4+ cdr2(1–590)-kcc4(917–1,037)–myc12
pMA32 pJK148-Pmid-mid1400–450, leu1+ mid1400–450
Fig. 5
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pAM18 pJK148-Pmid1-pom1-chimera–mCherry, leu1+ pom1(591–1,087)-mid1(500–920)–mCherry
Fig. 6
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pAM18 pJK148-Pmid1-pom1-chimera–mCherry, leu1+ pom1(591–1,087)-mid1(500–920)–mCherry
pMG52 pFA6a-kanMX6-Pcdr2-cdr2KD-mEGFP cdr2E177A-mEGFP
pSR135 pFA6a-kanMX6-Pcdr2-cdr2N-kcc4C–GFP cdr2(1–590)-kcc4(917–1,037)–GFP
pSR166 pFA6a-kanMX6-Pcdr2-cdr2NKD-kcc4C–GFP cdr2 (1–590) E177A-kcc4(917–1,037)–mEGFP
pSR182 pJK148-Pmid1-pom1-chimera–HA3, leu1+ pom1(591–1,087)-mid1(500–920)–HA3
– pFA6a-TagRFP::NatMX6 TagRFP
Fig. 7
pSR25 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cter GFP-cdr2(591–747)
pSR102 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cterbsc GFP-cdr2(620–747)
pAM18 pJK148-Pmid1-pom1-chimera–mCherry, leu1+ pom1(591–1,087)-mid1(500–920)–mCherry
pSM1275 pMAL-TEV-cdr2(518–620) MBP-TEV-cdr2(518–620)
pSM1294 pMAL-TEV-cdr2(518–620)bsc-4A MBP-TEV-cdr2(518–620)S604A S607A S616A S618A
pSR219 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cterbsc-3D GFP-cdr2(591–747)S604D S607D S616D
pSR282 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cterbsc-3A GFP-cdr2(591–747)S604A S607A S616A
Fig. 8
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pSR231 pFA6a-kanMX6-Pcdr2-cdr2bsc-3D-mEGFP cdr2S604D S607D S616D-mEGFP
pSR278 pFA6a-kanMX6-Pcdr2-cdr2bsc-3A-mEGFP cdr2S604A S607A S616A-mEGFP
pSR255 pFA6a-kanMX6-Pcdr2-cdr2KD-bsc-3D-mEGFP cdr2E177A S604D S607D S616D-mEGFP
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Table S2. List of plasmids used in this study (Continued)
Systematic name Developed name Details of expressed construct
pSR280 pFA6a-kanMX6-Pcdr2-cdr2KD-bsc-3A-mEGFP cdr2E177A S604A S607A S616A-mEGFP
pMA32 pJK148-Pmid-mid1400–450, leu1+ mid1400–450
pMA49 pJK148-Pmid-mid1nsm, leu1+ mid1nsm
Fig. S1
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pSR38 pFA6a-kanMX6-Pcdr2-cdr2bsc*-mEGFP cdr2K598N H599Q R600Q R601Q R602Q K612N K613N K614N-mEGFP
pSR106 pFA6a-kanMX6-Pcdr2-cdr2bsc-mEGFP cdr2591–619-mEGFP
 pJK148-Pcdr2-cdr2hlx1*-GFP, leu1+ cdr2F626A L627A F630A F631A-GFP
pSR11 pJK148-Pcdr2-cdr2hlx2*-GFP, leu1+ cdr2L648A I652A V655A L656A W659A-GFP
pSR12 pJK148-Pcdr2-cdr2hlx3*-GFP, leu1+ cdr2F720A L723A-GFP
pSR165 pGEX6p1-GST–cdr2-Cter GST-cdr2(591–775)
– pGEX6p1 GST
Fig. S2
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pSR38 pFA6a-kanMX6-Pcdr2-cdr2bsc*-mEGFP cdr2K598N H599Q R600Q R601Q R602Q K612N K613N K614N-mEGFP
pSR84 pFA6a-kanMX6-Pcdr2-cdr2FF*-mEGFP cdr2F704D F705D-mEGFP
pSR120 pFA6a-kanMX6-Pcdr2-cdr2bsc*FF*-mEGFP cdr2K598N H599Q R600Q R601Q R602Q K612N K613N K614N F704D F705D-mEGFP
pMA32 pJK148-Pmid-mid1400–450, leu1+ mid1400–450
pSR25 pFA6a-kanMX6-Pcdr2-GFP–cdr2-Cter GFP-cdr2(591–747)
Fig. S3
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pAM18 pJK148-Pmid1-pom1-chimera–mCherry, leu1+ pom1(591–1,087)-mid1(500–920)–mCherry
pMG52 pFA6a-kanMX6-Pcdr2-cdr2KD-mEGFP cdr2E177A-mEGFP
pSR84 pFA6a-kanMX6-Pcdr2-cdr2FF*-mEGFP cdr2F704D F705D-mEGFP
pSR139 pFA6a-kanMX6-Pcdr2-cdr2KD-FF*-mEGFP cdr2E177A F704D F705D-mEGFP
pMA32 pJK148-Pmid-mid1400–450, leu1+ mid1400–450
 pFA6a-TagRFP::NatMX6 TagRFP
Fig. S4
pSM1192 pGEX-4T-1–cdr2(518–620) GST-cdr2(518–620)
pSM1193 pGEX-4T-1–cdr2(518–620)604-607-2A GST-cdr2(518–620)S604A S607A
pSM1194 pGEX-4T-1–cdr2(518–620)604-607-616-618-4A GST-cdr2(518–620)S604A S607A S616A S618A
pSM1195 pGEX-4T-1–cdr2(518–620)616-618-2A GST-cdr2(518–620)S616A S618A
pSM1196 pGEX-4T-1–cdr2(518–620)618A GST-cdr2(518–620)S618A
pSM1318 pGEX-4T-1–cdr2(518–620)604-607-616-3A GST-cdr2(518–620)S604A S607A S616A
pSM1319 pGEX-4T-1–cdr2(518–620)604-607-618-3A GST-cdr2(518–620)S604A S607A S618A
pSM1310 pGEX-4T-1–pom1 GST-pom1
pSM972 pGEX-4T-1–pom1KD GST–pom1-2
Fig. S5
pSR34 pFA6a-kanMX6-Pcdr2-cdr2-mEGFP cdr2-mEGFP
pSR231 pFA6a-kanMX6-Pcdr2-cdr2bsc-3D-mEGFP cdr2S604D S607D S616D-mEGFP
pSR278 pFA6a-kanMX6-Pcdr2-cdr2bsc-3A-mEGFP cdr2S604A S607A S616A-mEGFP
pSR234 pFA6a-kanMX6-Pcdr2-cdr2bsc-3R-mEGFP cdr2S604R S607R S616R-mEGFP
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Table S3. Cell length at division in mutants of the C-terminal– 
anchoring domain
Strain Genotype Length at division
µm
AP752 Wild type 13.5 ± 1.2 (148)
AP2804 cdr2 17.9 ± 1.2 (315)
AP3087 cdr2-mEGFP 13.6 ± 0.8 (427)
AP3418 cdr2RR*-mEGFP 13.4 ± 0.9 (349)
AP3568 cdr2RKRKR*-mEGFP 15.4 ± 1.1 (324)
AP3526 cdr2bsc-mEGFP 14.8 ± 1.1 (502)
AP3112 cdr2bsc*-mEGFP 14.9 ± 0.8 (236)
AP3548 cdr2RR*-RKRKR*-mEGFP 17.2 ± 1.1 (188)
AP3546 cdr2bsc*-RKRKR*-mEGFP 17.7 ± 1.1 (214)
AP4249 cdr2FF*-mEGFP 16.2 ± 1.1 (189)
AP3136 cdr2hlx1*-GFP 18.4 ± 1.2 (108)
AP3140 cdr2hlx2*-GFP 19.1 ± 1.3 (206)
AP3142 cdr2hlx3*-GFP 18.7 ± 1.3 (163)
Mean length at division ± SD with (n) number of cells analyzed, grouped from 
three or more experiments.
